var title_f28_5_28752="Component separation technique skin flap dissection";
var content_f28_5_28752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Component separation technique skin flap dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The first surgical step for performing the component separation technique (CST) is to elevate the skin and subcutaneous tissues from the underlying fascia. The dissection extends from the costal margin cephalad to the pubis caudally, and to the anterior axillary line and iliac crest laterally.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Nguyen VT and Shestak KC. Separation of anatomic components method of abdominal wall reconstruction--clinical outcome analysis and an update of surgical modifications using the technique. Clin Plast Surg. 2006; 33:247.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28752=[""].join("\n");
var outline_f28_5_28752=null;
var title_f28_5_28753="Lymphocyte subset anal II";
var content_f28_5_28753=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphocyte subset analysis by flow cytometry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 300px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow cytometric profile of an individual's peripheral blood affected by SCID (T-B-NK-).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28753=[""].join("\n");
var outline_f28_5_28753=null;
var title_f28_5_28754="Superfic inguinal lymph nodes";
var content_f28_5_28754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Anatomic view of the superficial inguinal lymph nodes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 409px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mann WJ, Stovall TG. Gynecologic Surgery. Churchill Livingstone, New York 1996. Copyright &copy; 1996 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28754=[""].join("\n");
var outline_f28_5_28754=null;
var title_f28_5_28755="Atrial septal defect PA";
var content_f28_5_28755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atrial septal defect with pulmonary arterial hypertension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 285px; height: 333px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFNAR0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxL4L/AA7/AOFl+KLrR/7U/szyLN7vzvs/nbtrom3buX+/nOe1e0f8Ml/9Tr/5Sv8A7dXifwf1698PeJri6067ltZZLRojJF12l0OPplRXulp478XvtkTWbh4vX5Tn9KAIP+GSj/0On/lK/wDt1H/DJJ/6HX/ylf8A26r7/EPxWpP/ABM5jj0C/wCFNX4neJ05bUpj7FEP9KAKX/DJP/U6/wDlK/8At1H/AAySe3jX/wApX/26tKH4seIg+1r4gerQp/hWxY/E/X5iAbqJvpEv+FAHJf8ADJcm7H/CZLj1/sz/AO3V5b8SfhI/gvxEdLTVzfoIkkM4tPLALZ4xvb+dfTcHjrW5xmO8jz6eSOK52/0iTVLya9vmM00zFnf1P0/pQB8vJ4QdyALvk/8ATL/69adh8OZ7yQIt9t9T5PT/AMer6Rg8E6dcYLWeG7sOK0I/DdnpKF40W4Zekaj+dAHzzcfB54Yw51nORnH2T/7OqkPwpllbamqEt6fZv/s69+ezmvpWmuVMa54XHT2FWYdNVEwiCNT3PU0AeFW3wXkmYIdbw/cC0zj/AMfq/H8B2cgHxDj/ALcc/wDtSvYbq9sNIiPIL9z61Rh8UQzHKOIx2z3oA82j/Z8MhAHibBPY2H/2yrCfs5sxH/FUYHqdP/8Atterw+IFBBwHT16Gul03Ube6iUoM57E80AeJ237MizDjxeFPp/Zv/wBtq0P2WGOf+Kv/APKZ/wDbq+htPiDYKjA9DWuI8KOelAHzF/wyxhC0njIKB/1DM/8AtaqFz+zQYmxH4sEg9f7Ox/7Vr6jvADC6hxzzWIUOeHBI96APn2y/ZiNzw3iwxn/sGZ/9q1af9lcr08Y5/wC4Z/8Abq+jNOWQFT29qvXBYRmgD5Tuv2a1gJH/AAlobH/UO/8AttZsn7PxUkDxLn/twx/7Ur6eu4FyS3Gf1rFvYQvzLge5oA+cLv4EvARjxBvz/wBOWP8A2pVCT4MSopI1rOP+nT/7Ovoi4iiZsM6t681mXVooy0TjPoTigD5xvfhm9q5U6nuI/wCnfH/s1UB4FfzApvwAe/k//ZV75qlgLlSkiYfHyuK5mXRpIn3bSyg9fT60AeRX/gua0LD7TvK9R5WP61kSaK6H/W/+O/8A1699i0uPULcRTACZeEbuRXN614VdNx8vdjuBQB4+2nEf8tP/AB2q8lsyZ5z+Fd1eaG6uQinPpiqZ8OXsqkrBIR/u0AcUQR1pK6mfw1eKDugYD3rNfRLheqY+poAyKK0JNLuE/hA/Gs+gDrvhnb/adenTGcWzH/x5K9o8PI1tKIZB+7c4Hsa8y+Atr9s8X3kZGcWDt/5Ej/xr3qLQHDAuNi9j3oAr3Oi4ydpwe4rKuNG+YnbwPavU9MtIp7ADy9zKMEmpotCiuMqbfk8ZFAHi50gl+FJFWbfR2RwUyGr3C18G2IffLDjHqabewWFlkWdlG7jje4yB+FAHAaNpN+Yi8gEcfTe3Fa9vrNrYSiIEXEg4OwZ/Wq+uLc3ErrLLI69lzgD2xVTTtKO5SVO8noKAOsTU4rz93zbk/r+NWIdLP32OE7Y71XtNOUOSw5HX0FM1jxBHotsW/wBYegX0+lAE2ryWlpCXuAq7R949q8x8T+ITFHI9lIZUP93rVXxL4hGtvlp9oH8Of6Vx17cFCdpJHrQBjax4juJWdpC2ATwTWJb69NJLlnYY6D0q1rcsczbWRQ3XcOtYDQyodwIdfagDstI12RZVPnFsepr0bQdXkd4pI5W3ZHfg14hYld44KsPSvRPCErMUjYkOOVPY/WgD6W8LX63MKmT74xXTggjGeK848B3PmwqZflkU447ivQ4yDGDnigB0kUZQ7hweKxjZRLMSsrBs1p3chSDIYZB9ao26+cxz97OeKAL9pgAAEDHb1p1wCwPpT44Qh96rareQ2VnJLM21VGaAMHxBfwabA0krAEDqT0rxTxV4/DSvHbMSAeuag+Iniq41i8aKHK26k7V7t715XqvmbiGbAPXNAHR3HjC787ersPq1Ni8aXiynLF4+4LZrgZ5FDEGSlt4ZJj+7xg984oA9i0rxOPlOW2t2PSu4skt9UgWa0ZfM/iX1rwvQIZY0xJK+0H7o5r0jwlra6dcJ5cYA/iI7igDrB4dmdzJHH5fPIbt7itD+yrVyv2jLy469Aa6LRbyDWIA8ThmHX1X61PdWEUI8yQgAdRQBwmpaVaOWVbZYHP8AGF61z17odxCj7idh6MOhrt9X1QWzMlrbB8d36Vyt/rMkrlW/dk8bX+4fxoA4bUNM3bhvOPrXM3emkZOelekXtldSW7SwwggjJA5/L1FcVqMU+48FT34oA5W7sWPGM/SuCr025s53J+ZvzrzKgD2X9laIS/EPUFZdwGlyH/yLDX1VNpO9egI7V8x/sfxiX4maiD20mQ/+Roa+yBEoGMUAY2k6cltAzOPvHgVq2yEZO0KPSpfLGelVdQkZR5UfQjk/0oALqeJ8xiXB74GaybhYogzM281Zjh4zjmoZ4GYdOPSgDl5LZppSx+8xzWzp2mhCG2/NjJJ7Vq2GnKx3svSp9QkisrdmJCgAkk96AOd1u5jsoipPAGT/APXrxHxv4gNxNKXkEcI4UE10HxA8UtskitGO5s5c/wBK8R1a4mmdmZi5PUk0AOudVVZmeMux9RwKSPxEz4SZEA6bq52ZnDHHFM27iNzjmgDW1R2k/eRuCPTFZkU7o4DCk+ZPlVyeKWBfMcZIyOx4zQBqWcsMo+fhs9uK9B8E27GVCm18dVB5xXmxtZVfIQ7PpXZ/D+9mg1m1Vx+7z3oA+gPCCrDL5LZVxkjjr9a7603SAqWXFcX4df7QY5QoLA85613dvCDGrYwaAIdQszJASJMY9BUVhbGFlIkUnuK0LhSy7QMjbzUFnCQ2TxQBbklWKPc5rhPGkr3dlKgbCt/Kus1Q469AOK868WXzJay7ASRjAoA8n1q08uWQIMn27V5/rNpI0jEsowfXNd3rkkylpMnJ7AV5/qZlLOG+XJoAxJIII2G5sv6k8U+C5jDBd+AOBUU8Qxjqe5x1qONApy2B7UAdbpEv7vPmqOehrorHUba1K/aRk9QRXm1xfNGgWIHOcU23vZozuEhyfXmgD2DSPF93ZXok09wiZ5B7ivavD2rQ65aJMDiXGHVq+S9N1Ybh5g2n+8v+Fev/AA318wXah3DROME54oA9O13Stp3qp2N+hrjdU0vcGO0/lXrFsEv7DK4bjNc5qVhsZhtBU9DigDzrR47uxugkDfKx5RuVNbd54bs/EUDSWWLe8AyyEcNWitiEuFfaMZrasYfs5WSID64oA8f1TwpeWMpSa3YKOrDmvmyv0JliS8t95TEg6471+e1AHvH7Gwz8TtT/AOwPL/6Ogr7I2nNfHX7GQz8UNU/7A8v/AKPgr7M2igCILhcnrVaSEMxJq4y8GoTQBAsI5qN4NzBQKt05F70ARMVhiLNwqjJNeceMdTkuo5wrbY+ijPau28RziKxwP4jjivHvFd15buJG2rjnJwBQB5z4huA1wwxk+prgNSLyOwwcA9q6nxFqMQcmAGRs/ePAritSllmLHdg91HAoAoy4R/3hGPTNNRoixxIoPQZNZ1xnce/vUAYCTFAGvHLiQEEHse9SgmSUDPzA8H2rHhJ+Y88VpWTlIiz9T070AdPpdwJV8qbHHQ+ldp4ZtQl3DK8Q2K3Y15naTkkbQwBPavV/BAa6WGH5SQwxnuKAPZvB8WWG05Ud89q761digQfnXH+FrY20ygZAwOBXdooUDCgUAVWnYO6FQSKmjLqmTgmpsDOcClx7UAZ95AWbeTxtxXn2v2aPdTDqm0jmvTp496FSK4TxeIrW3ZzwQDQB4b4wm8udljAworz3VQXw4XOa7LxDO0lw8qYPJODXD63eMIpYVADtzx2+lAGLd3CwqSAGfHTPSs9D5hLStk9evSo/KGw7zhs5571G77m5wMCgDSdEKcNye3pVcvgn16Vl+afMyDgU+C4cNuZvl7Z5oA2rbaCoBw3qeldb4XvJbS68yMkEcexri7S8UnbIv4ius0Y7B8hWRTyTQB9P/DXXBeWcfOHxhk/qK7a7s1ljJUcHke1eE/D+8MC70cgqemf5V7v4cvRf2IL/AOsX7w9RQBzt1YgE8YNVolMSEDjFdff2gJyB15rAu7YrkgYoArWGpSWtwqygNC3Dccj3FfAFfe0qZIIHNfBNAHvf7GP/ACVHVP8AsDS/+j4K+zsGvjL9jH/kqOqf9geX/wBHwV9p4yOaAIcHFQunNWytROvagCBUyakIwpqSNBg025wqenFAHH+MrqO3tjJK2FXoB1NfO/jrVjf3sgd9qLwqjtXsHjq98+WUvnywCoX0rwPXwDcy+YxHJoA5rUrlSp2ckdawbubdk7SD6itm+iwuVKlqyp13j0P86AMqaMMN2CPeqUkJ3c8Htmr1zvHykHAPSqzHK4bNABs8kDvmrkSs6Bh09M1UlfKAY/GprO58pwjDOecUAatpCx2YGM89a9H8FyS217bMFZRvGe1eeWt1vlTgZB6Yrt/Dd4rX1uGfYAwyDQB9MeG5fMKFstk/pXbp92vPPBoZ2jB3EAD5vavREHy8UAOVcipEHFIgyPwqZUO0UAVpBjJxXn/j+JpLWVR2Un3r0aZMLXM+J7VXspnPOUPagD5d14JEzb15H6157qgImkLHB7GvRfGckKXDRurDqTg4ry/VL2PznAy0ecEUAZ8tsZCx7j1OM1HPZoIhuJWQ0k90oCHPT3qjc3zuCA/Hp6UAQSxFS5znHFRqGLYHJqTeDEfm5ogI5B6+tAFuxXa+XyT7V0+izNA3mKdrDpiuatWI+6K3tO2syqRwepHUUAeq+Dr4XEieV+7kXkr2b3Fe/eCrjhWB5IAI9a+Y/DLNbzKYySFOQe4r6B8C33nW8b8CQfeA7j1oA9QljDIRWPe2uScjrWzC2+JW9RUU8QagDkprQq+MfjX561+lklpuJzX5p0Ae+fsY/wDJUdU/7A0v/o+CvtVPujNfFf7F3/JUtU/7A0v/AKPgr7VXoKAAjIqNxkVNimEc0AJGuKztXciNwPTk1qAYFYmr5aOQd2oA8q8bEG3cDIyc59a8Z8QRqgZyQT3zXrfjvUIbZGi+/MvYdq8R8QTtK7Et8pPSgDmNQuAMlRux3FYVxcyclTj6VqXW1i+Rg/zrDugw+4aAIZJZyuS5NRW5aRmDE80L12tnnrU9tZN5gdTj1oArSZRxv6UsR/fKwNWdbt3imViMqRniqsHLr169BQBv2UOS8rD7vJrR0m6P2tWUsDnpWdMrw2qoT8zD8qSzcrtwTkdaAPq34V6w0kFusm5uBx6V7LC6tECB15rwP4RIp02AAEu5AJzyK96hQLEqDooxQBahGe1WVHFMhTCCpaAIp1yvArk/GM/2XR5ZDwF612Nc14wsFv8ASbi3dcqw5oA+GPGuuvc6reFW+USMo57ZrhLq5aVmznmuw+JmknQ/E17bMCVMhIHsa4iYkcAYBoAs2kH2hNpkGfTvUNzbNCxz27VHbyeVMr+lWL2VmkDAnaaAKrDCjjBptSygsQenrmmcKT396ALtlJIhyRlcd66XSHhlZVZ9h9xXKQOectwPWtux5VcNyaAPS9AUKyhBknGD61694UlNu8bxjgYyBXiPhC98idfMy8f930+le0+GcFkmikDRuOKAPa9LkEtpGV5BHFWmGRWP4YfNsVH3QcitphigCErivzFr9PSK/MKgD379i3/kqWqf9gaX/wBHwV9qp0r4p/Yu/wCSpap/2Bpf/R8FfaqdKAHUUUUADfdNc14juDb2UrL985x7V0jfdP0rifG82yxcjqRQB4d4vnDTySFstnnNeXaw+GY7up5r0PX7aWZnZ/l9QOtcXqFguH2qQexPNAHFXKFidpOM9aoNau7YzgdjXrHgv4X6h4z0fWLzS7y1NzYgCO1ZxvmY846/ICAcMeCRj1I821CK4tp5IJonhniYo8bKQysOCCD0INAGX5BglxIckdxViwAe42Ajn+92qSELKQHxuHrV3QbOC+1IKJFUjnBOAfagBL3ymRRKQ/bpinWOnxfZXmaLlRlTnpXbDwh9qIQRlu+QMYNTSeGJ4rR7byTvXoTxkUAeb3nmHcwjIGeO9SachkYKw/Ad66i+8M38e3MTeWQTuIpfD2kC41CKAD52YAnHIoA+g/gRpLnSI7iVflByPf0r2mKMHbXKeA9KGkaDBCrbvlGDjFdZb5JGaALY6UUUUAFUNTTcjD1FX6rXo+QUAfG/7SuiiLUoNQjUhmyjnFeDTRswHABr7N+NvhuXWtPljWIsAC2cdPpXycdJkFzJbujAoxXkc0AY1hbLNNsZwG9K1fsANs+UJHUHHerkGgMWVzlNp6nitvUbFbezBY7MevegDjpbNSvAycetZgjAYhjjHFdRNbtNG7Rhdqr2Ncy67JG3dc9KAJreAMCxYDA4q5as4bphR3FVrVJHjYqrFVGTgZwMgZP4kD8a3vDeg6tr16LTRNPur6cYJjt42cqM9TjoPc8UAa2iXJEijJHPNex+CL77JKu9j5MmAw9/WuC8Q/D/AFrwW2mnxDFDby36M6LHJvKbSAVYj5c8g8E8EV1HhpZCseSDjGCKAPo7wqf3fBypGQa6J+lch8P5jJY7XOWTj8K7KReKAITX5gV+n5r8wKAPfP2Lzj4o6pj/AKA0v/o+CvtWM9a+Kv2Mf+So6p/2Bpf/AEfBX2pFwaAJKKKKAGy/6tselcX4uH7pQAM4JzXav90/SuO8VGNbdnbqBQB4l4qj2SPKSVU+nrXnWqXu1nRv9UfU12vjO/aeRlT7mcDHUV5bqoeWRuQCPU9aAJ/D/i2/8H69Fquiy+XcxEqQeUlQ4yjjupwOPoRggEexeKtC0j43eGT4l8FeXa+KoFC3unO6qZDjGGJwM/3ZOAwGDgjC/PlyqyEpGuT3Ndv8IPiQfhvqksk+j297Z3JVbiVFxdRpkZ2MTgjvsOASByOtAHI+NvCV/wCDPE1zousLtnhwUlUHZNGfuup7g8/Qgg8g1X8M2y22pJK7jZkGvo74zW2ifFz4cnxL4LuobvVNGj86WEYWdYDkvHIpwQRtZlzkHa23O7NfN3ho7rwGRcgdR7UAfSHhO/0iKa2eRizyKDt44rstSl06Y71iV2IwcLmvnfRr42V9lciFhkE+o7V63o14z2QYElXwQO+aAKvjTS0MSNE7JEVLBAOhFYnw18PNd+I/NdVManr/AI16UdMh1KJBcMOhGPrWp4b0W30w+VbrgZyxxy1AHaWS7YVTjavAx6VqQKetZ9r8qrx+daUH3aAJaKKKACorhNyVLQRkUAYmpWSXVs8T4+YYz6V8vfE7wdPpevG6iixDM2CR0Br6zmj4PFcf430SHUtOl86PeFU5Hp70AfN/hrw8kjPc3Khkj4A6/jWF47hinuktbNgwP3iB0rpNV1CTSmmt4o3BU7a5N7mJLlDLxuO4kj1oA6DStBth4fb93GJghUgjPGPWuS8A/BLxL441hmhibTtEDZbUrmM7GG4jES8GQ8HpgDHJGRn0JLq1i0MtFIu9l5weleM+Jtd1TUdYeS81S9vI1bC+dOz8dOMnjjj6UAfZ+keAvh74I8LXPh25+wR216qG7fULlVmucH5SzEg4yvAXAByQMk14l4k+P2o2ayaT4J0TTfDtjEzIHRElcEN1VVAjXIGCMP7GvCbmaIQyNEVV+OM1lwO3mZdjigD0yXxVqviG48zWL64v3LE7riQvsyckKOij2GBXfeEWCmLIIU8EV4po9w0cgOCBnp617D4EvBdui8HZyVPegD6B8FL5Plqn3GGa7l/u1w3gttzAY4AyK7nqv4UAQN1r8v6/UButfl/QB75+xh/yVHVP+wPL/wCj4K+01PSviv8AYx/5Kjqn/YGl/wDR8FfaSnigCeikU5paAGyfcb6V5x4+uGUso5UL0FejTf6pvpXlHxNk2xtIjYKjBoA8L8Tyl2l2lhk9K4G/3M5K5BFdnrF6WmZZOmfSuO1FP3rSbSfagDIedkkwxwB+tRSzlsqACDU7Wckrn5CB1q5ZadGccfPn+LtQBB4Z1XU9A1qG/wBFuprO+VhseI46HoR0ZfUHIPcGunysdzLcPbwRS3EhlMVvGERdxyQqjhR6AcCrvhrQoDLHNMQ0z9AR0HrituXRFNzlzgk4VsUAV9J0r7VbmSRSYxnYuO5rb02HVz5UMVvIqRH7x6V2nhLSLaysk+TzJCMszVty31ugKrGssx/gX+Z9KAMHRJb6OYRyZ5IJJPSvVLBAY4WDEk9a5HSrJbtzIV2yHgha7vSLUxW8YZcHHQ0AakC5GK0IhhAKhghwMmrFABRRRQAUUUUABGRzVaeEMp4qzQeaAPD/AIxeCzLbHUdNjAZT+8QV88eJ4JIbpEyA23qK+6dRtEngaN1yrDBBr5N+OPgyfTNZN7p6yNCfvjsp9RQB4te6tcws0O9tufm57Vk3t2JXwuFU8DAq7rFvKSQiHplmqkto0kOXUjHfFAFAfO/JPFWIoyp56mphbIqbQCZD3p0cLqwUj9KAL1g7MwUHC4xiu/8AB921pdwNC2CD+dcNZxkvjBA6fSuy8PxCOVW3dO1AH1j8PJhd2C3K4BI2sB2Nd2v3RXlvwlnYWQXdlXGMelepL/qxQBA/Wvy+r9QpfvV+XtAHvf7GX/JUdT/7A8v/AKPgr7QVc4r4t/Y0OPihqf8A2B5f/R8FfakfIoAlQYFOpE6UtAEdwcQtXkXxFkJaeMDcTwB1r1q8OIwPWvNfHMCiYsMbmHJoA+dtZsgZmMqN1zgHkVh3CbUIZQAeMV3XiK1VZXMYOCc5J6Vxl5DG5kklyiIOD6/WgDHKzAgIvyk9BVyGylvLqJFBQ569qqNfN5m22H7sdzXVfDq3bVNdVbjiOPlj7UAdT4ftorfUoA43rgKcCvSdO0lLuZg8CYVdw4zTdO0Cz+0Ewx56e9dvpVrFEYxApUqnX1oA8+1NLy3Yw26lQ52jtgUmmWskGIpBvLE7nPp6V389mGdzcRo5zw1Zk+lbWY7c7jwfSgDP0y22zKAsmAeMGvQtP3iOMOOcVzGlWVwJ1dydua7GzUs3PagC+OgooooAKKKKACiiigAooooAQjIrlPGeix6nYSIyISAc7h1FdZVe8iDxNx14NAHwj8R7JdJ1S5gEBWJmznHeuUigLxJGG5bnbX1P8Rfh9HqFzJK4yjZJO3Oa+ftd8Py6NqP2eQ5YE7Wx1WgDmptIZMy4PuOtJEqqFUx7mPArrNP050ZckFW5O4/pVHUhb2jrJEgLjORngUAVrW2C4+UHPJ9RW7pVrI0ymMEoOtZ1hcJdkNgIen1rtdFgjZ40Rcbe/Y0AexfC3EFvEuc8168nMdeYeCbXy1h+UA98dK9Pg5hFAEMor8vK/UWQcV+XVAHvH7G3/JT9T/7A8v8A6Ogr7RjbgV8W/scHHxP1L30iUf8AkaGvs6M/LQBdQ8U6mRfdFPoAq3x4UV5145c7JfmwVycmvRNRYLEGJ4GTXjnj/UQWYKcqeMetAHlWvXEbtJsYhl5z1zXO2ui63r+99P0u+u4VbYTbW7yAHjgkDHcfnXp3h/4cX/iax/tB72007ScuWuJDvfC5ydoIAAIwdzD15rtPB/ir4feCp59F0vWJ5gyvPc3ckhaHcg7dFLEcDy1O7AGSQKAPHbH4O+NLrCDRUtoD/wAtbi4jUD6gEt+lX/hvoMdvq+o20F/aX3kMFaazZmiJ77WYDd9QMHsSOar/ABc+LOpeMpDpmkCbTtC5DJuxJc89XI6Lj+AHHck8Yn+DbGKCXG7c/Ax60Ae3aFEYk8lIySeCRXV2dv5ajP3qxfDFlMih5WyOoHeunRdoyaAKF5beZGQMZrKhl2kGYEDOBmuhYA8VkXEEzXSRxqCmeT3oA1IcNGuzGCO1adumxB6moLK2EUKqecVboAKKKKACiiigAooooAKKKKACkYZBFLRQBlaharKpWQZBrxf4u+Era+sZDCFiu4xujYDH4V7rdxlhkVzmq6PFehjL85PZqAPiQ3Vza3Kw3DlZYWwwPFWri2jvHkAYLnmvVPi78OYLmd7vT90VwgORjhq8RlguLaTY7lJovlIzzQBet827+XHkMh5yPvV6D4NZrmeHLBZR/Ce9cPZH7RsaYbmz94Cuu0Fza3qMARt5BoA+jfCcbDy8r93GTmu5tv8AV15x8PdQkuolEmAT79a9Htv9WaAGSjrX5c1+o83evy4oA9x/ZBcJ8Tb8n/oFSf8Ao6GvtCM+lfEf7Ksoi+I94x4zpsg/8ixV9q2riSBGBzxQBqwHgVLVe26VYoAyfEbEafKF67Sa8I8WtneTktivdNdOYpBjIxjFeN+JLNXZxyTkjA60AeS397dfYnszNKLXf5gh3nZv6btvTOAOa594WlY7RyPwrvL/AEaTlnXAzg1kXOmmHDjIQDOe9AHOw2XyEMC7EcgDpXrHwqsUhhjfsRjHauDiOGXKbI8ncT1Nen/CGNZ1kil+TD/KO5FAHsfh6QiPymBDLzk961pHXdkGqVnB5C7Tgk1ejUORhaAI2yxyBxVu3t1jG4gbjzUqxqMcU+gAooooAKKKKACiiigAooooAKKKKACiiigAPIqrcRDFWqGAIwaAOb1fSYb6F0kUbmGM14X8QfhkJ0d4UEc45jZRwfavpCaHI+XrWddWiyIyyoDuGORQB8PiwutMuXtLhGilQ/MrfzrsNDjkkRS+BjgHtXsnjz4c2urIZ4BsuUGVYDr7GvKbaCSwvxZXVu0UinBz/OgD0/wExhkgcjjPbtXsNqPkNeUeGLfymiZXGO9er2HMQ5zxQAkw61+W9fqVMP5V+WtAHqP7Ospi8dzlTgmycf8AkSOvt3w+xfTYmJ5NfDv7Pwz46kA/59G/9Djr7j8PKRp0IoA37f7tTVHAMJUlAGNqqtIsgTk5rz/XLWNbk8gM3Vq9GnGWb8a43xFHFhieCOgAoA871axLMXEyhT1z3rmzpkpZkG6TccJjkV12r2xdNu/PHzVyX2y4huVhtzhEPBzQAuoaSYLVRcxbRnAPqa6rwCEspgVAWfqGNc7qt7PJYL9p6udowO/rWp8Pba61HWLcyMVs42C+7UAe86YDLEjS8kitVVCjgVnwfLwvAHArQTJUZoAWiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKjkTPapKKAM64twQRjKntXI+IvBlnqrpMAEmT7rY5+ld4y1CYgTQBwFjBDp7i3kUsw7Y4rutKYNBkDHHSq15p0Evzsoz61a09QgKg9qAJZhivyzr9TpxX5Y0Aesfs0QG4+IkiAZ/0Jz/5Ejr7k0+IRwRoBjAr4v/ZIi834nXY9NMkI/wC/sVfbVqvIoAuIMKKdRRQBnXOAxrhvEIZXdiCT2Artrsbi49a4/W3xM64BXFAHnWouzxzEElycYrAgsDJNwDuA/E129xp/mTSMpULj7p61BFYpa/NJjPXA5oAwY7Wzk2ves0ccZwATn9K9Z8F6XZrp8Vxar8jcrxivNZrcX2oRJIu2POAq85Fe26VBFaWFvDCu2NEAAoA0reIAA45qxUNuSQamoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKY9PpGGRQBTuFJUjNLZcN+FOm9qS1/1lAE8o4r8r6/VKTpX5W0Ae5/sfDPxQvvbSpf/R0NfbFqvevir9jkZ+J+o+2kSn/yNDX2xbDigCahuhopshwpoAzbgn5vpXKavHEztu4cenSuslHzGsa8tY/MYnknv6UAchNaSlXIJO49u4qhJE6FVuBjmuoubaQowU7VHQ5rIurchPNchgtAE2j21tNcR70CSFuPavQI0O0BR04rzTTrnfqltF93Mg5PavUYG2j1oAsW4IU561LTUcN0p1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBBMODUNrxNjPWrUgyMVXjGJM0AWn+7X5WV+qZ5WvysoA92/Y6kRPihqAdgN+kyqM+vnQn+lfbNv92vgz9mK4a3+I8rL1axdf/Ikf+FfdGmyFkUnuM0AaFRynjAqQkConPJxQBTlHNZl3hWKtyG56VqyMOhGaqz7G4YZJ6UAcrfyssb4zgelcze3ZaQLwQD+Fdlq4VIir7COu0VwWp27tKfK+UelADbC5P2uKZDnY+dw6da9fs5xNbJInRgDXkWnbLJSZUJUnpivT/C0wuNNgYHpxg9qAOhgGE561JSDAAGaXvQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAMcmoBw1WW5FV5BhqAJ1+5X5W1+p8ZyvNflhQB6b+z1J5Xj8t/wBOrD/x9K+7dDlElpE3XgV8B/BO4Fv43RicboWX/wAeX/Cvu3wnKJNNiIoA6J3+Y1HI+BmopX+c0xmJoARmyeazL69aIsqdfXFXZ2IUkHtWJcFphIDgZ4yetAHN61eS7mEZyzHk1iNcTHKyjcp6muhvbRoyzBA3HUVRg055+ZDsB9utAFbT3kvp1t4wWiXGcjpXpmiWy2FuqAY7msrRNIhs1Ro1+Y9Sa3en1oAuFtx61ZQ5UVno+OD0q5AxYZ7UAS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUABqvKecVLIcVXY5NAEiHCivyyr9Se1fltQB0vw/ma38QpKpwVTP/jwr7s+GV8t3oyOpyu0Gvg3wWcawf8Armf5ivr34IasINNeCdgFwzqT6AUAeqXuorDcmPPNTRT+YmVNeVz+IvN1qYhsrn+tdLpmsD5fmG0/rQB1k8m5TnOwVk3LBZGYrlc8CnJepJkEZ9qkkVJTuDbmz0HagDLdZGO7BHcD1rX0y0SeAPMP3oPTsKdb2bzMByCO9bttZiKMADOKAKyKV4AxUgUk9OatrCOMCp0jVRwKAKSwO3birkS7UxT6KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiikPSgCOU8GqxbB4qWY1VY0AOL89a/Lyv08dwvWvzDoA3fBpxrH/bM/zFfQuh3D2nhiWSFishjCKR75Jr548If8hb/gB/mK9xmleLwrBsJALDP5UAULXxGxv9tw5V+/vXbaT4jj2ooZs57mvFdSGbouSQQeK2vDmrG3uEW4QyqSMEDpQB9K+Hr4XhUYcs3GBXcadYkABgRk+vNcT8NHiu7dZU24wOnWvT7QDqaAJYLdIVAUVNRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFNLAUAKTimO9NeQYqF39aAElY1Ud8ZqZ245rJubgBnGeBQBHeXY8xVz3r816/QO9ugtxvL8D3r8/KANvwicat/wAAP8xXvEdsbvwwiqMkYOPzrwfwiM6t/wAAP8xX0h4UhEujxgDPH+NAHnV1oVxPL+7jOMda7HwT4TSAqbhS8xPcdBWtp1qZJzEOoY9K7zSdPCFSBz60Aa3hbSlsWUxHZ/umu8sbpyMNzjvXPWEQSMBR0HpW3ZRbEz3NAGxFOrcHipwc9KzUFWouOlAFiigUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFNKA06igCB4P7rVXeJwecVfNV5TQBSYEV594g1ZbK4lEzCMc/ePWvQpm6mvEPjPPEsEhdgOcr60AZOoeLIZ3ZIGygPJ9a+RK9Nk1O5j3RwhgB/EeteZUAbfhH/AJCw/wBw/wAxX0p4Dk3WkC4B6ivlCigD7dstIEWps6jg84rtNPtVwOOfWvzuooA/TC0tgq5q8owMV+YNFAH6ioOasxDivyxooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VSivyrooA/VTNIWAr8rKKAP1T3r60m9c4zX5W0UAfqdJIBVWWbrgV+XdFAH6T63dypEyxnacde9eKeOLIX0pNwSxHOTXyHRQB7FqFgFuwFHVsYrx2iigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plain frontal chest radiograph in a patient with a known atrial septal defect demonstrates typical features including an enlarged right atrium and right ventricle with marked prominence of the hilar or proximal pulmonary arterial vasculature (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28755=[""].join("\n");
var outline_f28_5_28755=null;
var title_f28_5_28756="Fluticasone (nasal): Patient drug information";
var content_f28_5_28756=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fluticasone (nasal): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/3/30773?source=see_link\">",
"     see \"Fluticasone (nasal): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/45/32468?source=see_link\">",
"     see \"Fluticasone (nasal): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9349460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Flonase&reg;;",
"     </li>",
"     <li>",
"      Veramyst&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9349461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Fluticasone&reg;;",
"     </li>",
"     <li>",
"      Avamys&reg;;",
"     </li>",
"     <li>",
"      Flonase&reg;;",
"     </li>",
"     <li>",
"      ratio-Fluticasone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10237426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness. It may take 2 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702152",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to fluticasone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699040",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad nose irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use in your nose only. Keep out of your mouth and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694567",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blow your nose before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694631",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Close 1 nostril.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696128",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head forward a little.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695230",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put nose spray tube into other nostril.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696276",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       While breathing in, press down once to release spray.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694569",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Breathe out from your mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694582",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your puffer (inhaler) use checked with your doctor at each visit. Read and follow facts on how to use the puffer. Make sure you use the puffer the right way.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Throw away any part not used after labeled number of doses are used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699408",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store upright with the cap on.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11688 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-194.187.108.93-5353394DC6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28756=[""].join("\n");
var outline_f28_5_28756=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349460\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349461\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10237426\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031115\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031114\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031119\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031120\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031122\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031117\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031118\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031123\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031124\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?30/3/30773?source=related_link\">",
"      Fluticasone (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/45/32468?source=related_link\">",
"      Fluticasone (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?25/32/26120?source=related_link\">",
"      Fluticasone (oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/33/12822?source=related_link\">",
"      Fluticasone (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/29/25047?source=related_link\">",
"      Fluticasone (oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/19/44340?source=related_link\">",
"      Fluticasone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?14/54/15204?source=related_link\">",
"      Fluticasone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/7/27764?source=related_link\">",
"      Fluticasone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_5_28757="Posterior elbow dislocation with radial head fracture";
var content_f28_5_28757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70331&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70331&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Posterior elbow dislocation with radial head fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) AP and lateral radiographs of the elbow. Posterior elbow dislocation with an associated radial head fracture caused by a fall from a skateboard in a 16-year-old boy.",
"    <br>",
"     (B) Same patient. Radial head fracture is more easily seen on the post-reduction radiographs.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Paula Schweich, MD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28757=[""].join("\n");
var outline_f28_5_28757=null;
var title_f28_5_28758="Opioid withdrawal in the emergency setting";
var content_f28_5_28758=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Opioid withdrawal in the emergency setting",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Andrew Stolbach, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Robert S Hoffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28758/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/5/28758/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opiates, extracted from the poppy plant (Papaver somniferum), have been used recreationally and medicinally for millennia. Opiates belong to the larger class of drugs, the opioids, which include synthetic and semi-synthetic drugs, as well.",
"   </p>",
"   <p>",
"    The Drug Abuse Warning Network in the United States estimates there were 162,137 heroin-related emergency department visits and 37,007 unspecified opiate-related emergency department visits in 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition to opioid overdose, a significant number of these visits related to opioid withdrawal.",
"   </p>",
"   <p>",
"    This topic review will discuss the clinical features and management of opioid withdrawal in the emergency setting. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68306 \" href=\"UTD.htm?22/15/22780\">",
"     table 1",
"    </a>",
"    ). Discussions of opioid withdrawal during detoxification treatment, opioid intoxication, opioid withdrawal in neonates, and general management of the poisoned patient are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1191?source=see_link\">",
"     \"Opioid detoxification during treatment for addiction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeated, regular use of opioids produces tolerance that predisposes an individual toward withdrawal. Chronic opioid exposure causes adaptations that increase excitability in neurons in the locus ceruleus, the major noradrenergic center in the brain. The presence of opioids brings these neurons toward their normal firing rates [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast number of opioids precludes presenting pharmacokinetic data for each one here. A few clinically important generalizations can be made. The majority of opioids have volumes of distribution of 1 to 10",
"    <span class=\"nowrap\">",
"     L/kg,",
"    </span>",
"    which makes removal of a significant quantity of drug by hemodialysis impossible. They have variable protein binding (from 89 percent for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    to 7.1 percent for hydrocodone) and are renally eliminated. Many opioids are metabolized to active metabolites. Examples include hydrocodone (metabolized to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    by Cytochrome [CY] P2D6) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    (metabolized to morphine-6-glucuronide). Cytochrome P polymorphisms cause variations in clinical effect.",
"   </p>",
"   <p>",
"    The most clinically important pharmacokinetic difference is a wide variation in serum half-life (",
"    <a class=\"graphic graphic_table graphicRef70480 \" href=\"UTD.htm?1/2/1070\">",
"     table 2",
"    </a>",
"    ). The half-life data in these tables, taken from healthy subjects receiving therapeutic doses, should only serve as a rough guide to duration of clinical effect. Actual effects are influenced by dose, an individual's tolerance, and the presence of active metabolites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES OF OPIOID WITHDRAWAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is often difficult to differentiate drug-seeking behavior from true withdrawal. It is also often (erroneously) asserted that opioid withdrawal is never life-threatening. While this conventional wisdom is usually true for \"naturally occurring\" withdrawal, iatrogenic withdrawal (from a reversal agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    , as in the setting of Ultra Rapid Opioid Detoxification) can produce sudden surges in catecholamines and hemodynamic instability that some patients may not tolerate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;In opioid-dependent individuals, opioid withdrawal may begin immediately after receiving an antagonist, or after cessation of use. Partial agonists (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    ) and agonist-antagonists (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/48/29446?source=see_link\">",
"     pentazocine",
"    </a>",
"    ) can also produce withdrawal, so for the purpose of this review, the term \"antagonist\" will be discussed in relation to these drugs as well.",
"   </p>",
"   <p>",
"    Signs and symptoms of withdrawal may begin 6 to 12 hours after the last dose of a short-acting opioid and 24 to 48 hours after cessation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    . Withdrawal symptoms typically peak within 24 to 48 hours of onset, but may persist for several days with short-acting agents and up to two weeks with methadone.",
"   </p>",
"   <p>",
"    Patients experiencing opioid withdrawal may complain of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dysphoria and restlessness",
"     </li>",
"     <li>",
"      Rhinorrhea and lacrimation",
"     </li>",
"     <li>",
"      Myalgias and arthralgias",
"     </li>",
"     <li>",
"      Nausea, vomiting, abdominal cramping, and diarrhea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some or all of these symptoms may be present, and the severity depends on the individual's tolerance to opioids, the continued presence of opioid in the serum and end organs, and the duration of time over which the withdrawal has occurred. As an example, a person who is tolerant to 200",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    who was administered two milligrams of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    intravenously would experience much more severe symptoms than someone taking 10 mg of methadone daily who stopped abruptly (ie, \"cold turkey\"). A thorough history should ascertain why the patient discontinued opioid use, to ensure there is not another underlying medical condition that precluded them from obtaining the drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid withdrawal is characterized by mydriasis (pupillary dilation), yawning, increased bowel sounds, and piloerection (",
"    <a class=\"graphic graphic_table graphicRef81045 \" href=\"UTD.htm?21/47/22267\">",
"     table 3",
"    </a>",
"    ). If the patient is in severe distress, heart rate, blood pressure, and respiratory rate may be increased. Hypotension may be present in the setting of volume depletion from vomiting and diarrhea. Temperature is normal and, with the exception of very severe cases, mental status is preserved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid withdrawal may appear similar to other withdrawal or intoxication syndromes. Most patients in opioid withdrawal have good insight into their problem, so the diagnosis is usually established by history alone. When present, the findings of yawning and lacrimation are helpful because of their specificity.",
"   </p>",
"   <p>",
"    Unlike opioid withdrawal, ethanol and sedative-hypnotic withdrawal may produce seizures and hyperthermia.",
"   </p>",
"   <p>",
"    Ethanol, sedative-hypnotic, and opioid withdrawal can all present with a broad spectrum of severity and vital sign abnormalities, but the first two syndromes are much more likely to cause significant hypertension and tachycardia. Many patients in opioid withdrawal have a pulse and blood pressure within normal limits. Although some in opioid withdrawal have a tachycardia that reflects their agitation, discomfort, or hypovolemia, only a small minority of patients manifest both hypertension and tachycardia. When present, these signs are almost always a result of a surge in catecholamines from iatrogenically-induced withdrawal. Conversely, in ethanol and sedative-hypnotic withdrawal, normal vital signs are the exception rather than the rule.",
"   </p>",
"   <p>",
"    Sympathomimetic intoxication may produce mydriasis, agitation, tachycardia, and hypertension, but these findings are usually much more severe than occur in opioid withdrawal.",
"   </p>",
"   <p>",
"    Cholinergic agents, which can cause diarrhea and vomiting, can be distinguished from opioid withdrawal syndrome by salivation, bradycardia, and altered level of consciousness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with opioid intoxication can be managed without laboratory studies. If the patient presents with a history of significant vomiting or diarrhea, it is prudent to obtain a basic metabolic profile to help assess fluid and electrolyte abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Opioid agonist therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68306 \" href=\"UTD.htm?22/15/22780\">",
"     table 1",
"    </a>",
"    ). If withdrawal was produced by an interruption in opioid use, symptoms can be managed with either opioids or with non-opioid adjuncts (",
"    <a class=\"graphic graphic_table graphicRef54978 \" href=\"UTD.htm?37/35/38460\">",
"     table 4",
"    </a>",
"    ).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     Methadone",
"    </a>",
"    is a good choice for opioid replacement therapy because of its long duration of action. Decades of clinical experience have validated the use of methadone in the management of opioid withdrawal.",
"   </p>",
"   <p>",
"    We recommend",
"    <strong>",
"     against",
"    </strong>",
"    routine administration of a full daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    maintenance dose to an unfamiliar patient who has missed a single dose. Some patients intentionally take reduced doses in order to save a portion, so their prescribed dose may be sold or abused. Twenty milligrams of orally administered methadone or 10 milligrams of intramuscular methadone are usually sufficient to relieve withdrawal symptoms without producing opioid intoxication. We recommend the intramuscular route, since the nauseated withdrawing patient may vomit after an oral dose.",
"   </p>",
"   <p>",
"    Like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    is used as substitution therapy to treat opioid dependence. It can be given daily, or several times a week to patients as part of maintenance therapy. Buprenorphine is formulated alone for intravenous and oral administration, and as an oral formulation combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    to discourage intravenous diversion. We suggest that buprenorphine",
"    <strong>",
"     not",
"    </strong>",
"    be used routinely to treat acute opioid withdrawal.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     Buprenorphine",
"    </a>",
"    is a partial agonist (ie, it exerts both opioid agonist and antagonist effects), and therefore a theoretical ceiling exists for its potential to cause respiratory depression [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/3\">",
"     3",
"    </a>",
"    ]. This feature, combined with its long duration of action, make buprenorphine a theoretically attractive therapy for acute opioid withdrawal. However, the complex pharmacology of buprenorphine creates problems that do not exist with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    First, as a partial agonist,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    will produce withdrawal in an opioid intoxicated patient. If a clinician's diagnosis of opioid withdrawal is incorrect the patient's condition can be made worse by buprenorphine. Second, the drug has a high affinity for opioid receptors, which may require a large dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    to overcome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/4\">",
"     4",
"    </a>",
"    ]. Third, unlike",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , there is no well-established, safe, empiric dose of buprenorphine.",
"   </p>",
"   <p>",
"    In the acute setting, there is a clear role for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    treatment in those individuals presenting with opioid withdrawal after missing their regular doses of buprenorphine. Otherwise, unless the clinician is familiar with buprenorphine administration,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    should remain the drug of choice for managing opioid withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Non-opioid adjunctive medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68306 \" href=\"UTD.htm?22/15/22780\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    While opioids are intuitively the ideal agent to treat opioid withdrawal, there are situations when their use is undesirable. As an example, when withdrawal is triggered by an antagonist, it might be difficult to give enough opioid to overcome the antagonist, and rebound opioid intoxication would ensue. Another example would be an individual experiencing withdrawal after intentionally stopping use of opioids to treat an addiction. In such situations, nonopioid adjuncts may be used to manage symptoms. In patients with normal or elevated blood pressure,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    can be administered. Clonidine binds to a central alpha 2 adrenergic receptor that shares potassium channels with opioids, and blunts symptoms of withdrawal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/5\">",
"     5",
"    </a>",
"    ]. While monitoring heart rate and blood pressure, the clinician can give clonidine 0.1 to 0.3 mg orally every hour until symptoms resolve.",
"   </p>",
"   <p>",
"    Although significant hypertension and tachycardia precipitated by a short-acting antagonist are expected to resolve after brief observation, hemodynamic instability induced by a long-acting drug (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    ) requires pharmacologic management. The clinician should use clinical judgment to determine which patients require more intensive management. As an example, a young patient may tolerate a heart rate of 120, whereas an older person with coronary artery disease should not be allowed to remain hypertensive and tachycardic for any prolonged period.",
"   </p>",
"   <p>",
"    Benzodiazepines are a good supplement to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    therapy because they have an excellent safety profile and clinicians are familiar with their dosing and administration. While not studied well in humans, other GABAergic drugs reduce catecholamine release during severe withdrawal, and the benzodiazepines themselves have been shown to improve withdrawal in animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In addition to clonidine, we use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    , in 10 to 20 mg intravenous aliquots, given every 5 to 10 minutes until adequate sedation and hemodynamic stability are achieved. Benzodiazepines may also be helpful in suppressing muscle cramps.",
"   </p>",
"   <p>",
"    Other withdrawal symptoms can be addressed specifically. Antiemetics can be given as needed to control nausea and vomiting.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15688?source=see_link\">",
"     Promethazine",
"    </a>",
"    , 25 mg intramuscularly or intravenously, may be a good choice because of its anticholinergic properties.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     Loperamide",
"    </a>",
"    , 4 mg orally, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    50 mcg subcutaneously, may help with diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Ultrarapid opioid detoxification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrarapid Opioid Detoxification (UROD) has been extensively promoted as a faster, more comfortable means of stopping use. In this practice, opioid antagonists are administered under general anesthesia or heavy sedation with the intent of producing withdrawal. In theory, after emerging from anesthesia, the patient has already \"slept\" through the most difficult period of withdrawal symptoms. Induction may be a better term than detoxification, since the intent of the procedure is not an immediate cure of opioid dependence, but rather a rapid transition to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    maintenance therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/8\">",
"     8",
"    </a>",
"    ]. Immediately after the procedure, the patient will still experience withdrawal symptoms, and anxiety and depression may last for weeks to months. Often patients are prescribed agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    , and antiemetics to help control withdrawal symptoms at home.",
"   </p>",
"   <p>",
"    The procedure is controversial, because it exposes people to the risks of general anesthesia, as well as seizures and hemodynamic instability, without a clear benefit. For these reasons, we do not recommend its use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1191?source=see_link\">",
"     \"Opioid detoxification during treatment for addiction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Generally, a patient presenting with symptoms of withdrawal following UROD can be treated like any other patient in withdrawal. Because these individuals are usually given",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"     naltrexone",
"    </a>",
"    , it may be difficult to treat them with opioid agonists. If a patient with implantable subcutaneous naltrexone beads presents in extremis, the beads should be removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     NEONATAL AND PEDIATRIC CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Neonatal withdrawal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal abstinence syndrome (NAS) is the term used to describe neonatal withdrawal from substances they were exposed to in utero [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/9\">",
"     9",
"    </a>",
"    ]. Symptoms of NAS include autonomic (sweating, low-grade fever), neurologic (irritability, high-pitched cry, decreased sleeping, myoclonus, tremors, hyperreflexia, yawning, seizures), and gastrointestinal (vomiting, diarrhea, poor feeding) features, and typically begin within 48 to 72 hours of birth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28758/abstract/10\">",
"     10",
"    </a>",
"    ]. Pharmacological treatment of NAS should be conducted in close consultation with an experienced neonatologist. Possibly more important than the choice of agent is the consistent use of an effective clinical scoring tool to guide treatment. A detailed discussion of NAS is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pediatric withdrawal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill children are often given opioids to treat pain and anxiety, and can develop tolerance after prolonged therapy. We recommend an oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    wean as a bridge to discontinuation of opioids to prevent withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeated, regular use of opioids produces tolerance that predisposes an individual toward withdrawal. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68306 \" href=\"UTD.htm?22/15/22780\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is often difficult to differentiate drug-seeking behavior from true withdrawal. It is also often (erroneously) asserted that opioid withdrawal is never life-threatening. While this conventional wisdom is usually true for \"naturally occurring\" withdrawal, iatrogenic withdrawal (from a reversal agent such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      ) can produce sudden surges in catecholamines and hemodynamic instability that some patients may not tolerate. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features of opioid withdrawal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms of withdrawal may begin 6 to 12 hours after the last dose of a short-acting opioid and 24 to 48 hours after cessation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      . Withdrawal symptoms typically peak within 24 to 48 hours of onset, but may persist for several days with short-acting agents and up to two weeks with methadone. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients experiencing opioid withdrawal may complain of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dysphoria and restlessness",
"     </li>",
"     <li>",
"      Rhinorrhea and lacrimation",
"     </li>",
"     <li>",
"      Myalgias and arthralgias",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nausea, vomiting, abdominal cramping, and diarrhea",
"      <br/>",
"      <br/>",
"      Some or all of these symptoms may be present, and severity depends upon the individual's tolerance to opioids, the continued presence of opioid in the serum and end organs, and the duration of time over which the withdrawal has occurred. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Opioid withdrawal is characterized by mydriasis, yawning, increased bowel sounds, and piloerection (",
"      <a class=\"graphic graphic_table graphicRef81045 \" href=\"UTD.htm?21/47/22267\">",
"       table 3",
"      </a>",
"      ). If the patient is in severe distress, heart rate, blood pressure, and respiratory rate may be increased. Hypotension may be present in the setting of volume depletion from vomiting and diarrhea. Temperature is normal and, with the exception of severe cases, mental status is preserved.",
"     </li>",
"     <li>",
"      Unlike opioid withdrawal, ethanol and sedative-hypnotic withdrawal may produce seizures and hyperthermia. Ethanol, sedative-hypnotic, and opioid withdrawal can all present with a broad spectrum of severity and vital sign abnormalities, but the first two syndromes are much more likely to cause significant hypertension and tachycardia. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If withdrawal was produced by an interruption in opioid use, symptoms can be managed with either opioids or with non-opioid adjuncts (",
"      <a class=\"graphic graphic_table graphicRef54978 \" href=\"UTD.htm?37/35/38460\">",
"       table 4",
"      </a>",
"      ). We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      be given in this setting (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Twenty milligrams of orally administered methadone or 10 milligrams of intramuscular methadone are usually sufficient to relieve withdrawal symptoms without producing opioid intoxication. We use the intramuscular route, since the nauseated withdrawing patient may vomit after an oral dose. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Opioid agonist therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In situations where the use of opioids (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      ) is undesirable, nonopioid adjuncts may be used to manage symptoms. Examples of such situations include withdrawal triggered by an antagonist and withdrawal after intentionally stopping use of opioids to treat an addiction. In patients with normal or elevated blood pressure, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). While monitoring heart rate and blood pressure, the clinician can give clonidine 0.1 to 0.3 mg orally every hour until symptoms resolve. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Non-opioid adjunctive medications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although significant hypertension and tachycardia precipitated by a short-acting antagonist are expected to resolve after brief observation, hemodynamic instability induced by a long-acting drug (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/16/39173?source=see_link\">",
"       naltrexone",
"      </a>",
"      ) requires pharmacologic management. Patients who may require more intensive management include the elderly and those with cardiovascular disease. Benzodiazepines are a good supplement to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      therapy. In addition to clonidine, we use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      , in 10 to 20 mg intravenous aliquots, given every 5 to 10 minutes until adequate sedation and hemodynamic stability are achieved. Treatment for other symptoms is described above. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Non-opioid adjunctive medications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A detailed discussion of Neonatal Abstinence Syndrome is found elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"       \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-28, DHHS Publication No. (SMA) 06-4143, Rockville, MD 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/2\">",
"      Nestler EJ. Under siege: The brain on opiates. Neuron 1996; 16:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/3\">",
"      Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 2006; 96:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/4\">",
"      Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 1985; 57:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/5\">",
"      Aghajanian GK, Wang YY. Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 1987; 26:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/6\">",
"      Elman I, D'Ambra MN, Krause S, et al. Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes. Drug Alcohol Depend 2001; 61:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/7\">",
"      Suzuki T, Tsuda M, Narita M, et al. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. Life Sci 1996; 58:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/8\">",
"      Streel E, Verbanck P. Ultra-rapid opiate detoxification: from clinical applications to basic science. Addict Biol 2003; 8:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/9\">",
"      Johnson K, Gerada C, Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 2003; 88:F2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28758/abstract/10\">",
"      Beauman SS. Identification and management of neonatal abstinence syndrome. J Infus Nurs 2005; 28:159.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 306 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-D438A33F91-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28758=[""].join("\n");
var outline_f28_5_28758=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES OF OPIOID WITHDRAWAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Opioid agonist therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Non-opioid adjunctive medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ultrarapid opioid detoxification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      NEONATAL AND PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Neonatal withdrawal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pediatric withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/306\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/306|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/15/22780\" title=\"table 1\">",
"      Opioid withdrawal - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/2/1070\" title=\"table 2\">",
"      Common opioids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/47/22267\" title=\"table 3\">",
"      Clinical features of opioid withdrawal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/35/38460\" title=\"table 4\">",
"      Opioid withdrawal treatment medications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=related_link\">",
"      Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1191?source=related_link\">",
"      Opioid detoxification during treatment for addiction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_5_28759="Cytokeratin stain Merkel cell";
var content_f28_5_28759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunohistochemistry of Merkel cell skin cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High-power photomicrograph of a hematoxylin and eosin-stained section of a skin biopsy, immunostained for cytokeratin expression (CK 20). CK 20-positive cells have conspicious brown-stained paranuclear dots.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mosby-Wolfe, Times Mirror International Medical Publishers, from: McKee, PH, Pathology of the skin, 2nd edition, 1996. Copyright &copy; 1996 Harcourt Publishers Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28759=[""].join("\n");
var outline_f28_5_28759=null;
var title_f28_5_28760="Aerial yellowjacket nest";
var content_f28_5_28760=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Aerial yellow jacket nest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 344px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nancy Bresich, PhD and Albert Greene, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28760=[""].join("\n");
var outline_f28_5_28760=null;
var title_f28_5_28761="Approaches to reduction of maternal mortality in resource-limited settings";
var content_f28_5_28761=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approaches to reduction of maternal mortality in resource-limited settings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Haywood L Brown, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Maria J Small, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28761/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/5/28761/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H16872044\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2000, 189 nations pledged to free people from extreme poverty and multiple deprivations. This pledge became the eight Millennium Development Goals, which are [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      End poverty and hunger",
"     </li>",
"     <li>",
"      Universal education",
"     </li>",
"     <li>",
"      Gender equality",
"     </li>",
"     <li>",
"      Child health",
"     </li>",
"     <li>",
"      Maternal health",
"     </li>",
"     <li>",
"      Combat human immunodeficiency virus",
"      <span class=\"nowrap\">",
"       (HIV)/acquired",
"      </span>",
"      immune deficiency syndrome (AIDS)",
"     </li>",
"     <li>",
"      Environmental stability",
"     </li>",
"     <li>",
"      Global partnership",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The specific target for maternal health is to reduce each country&rsquo;s 1990 maternal mortality ratio (MMR) by three quarters by 2015 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/2\">",
"     2",
"    </a>",
"    ]. This will require the involvement of health systems, communities, and families globally, and necessitate addressing political, economic, social, technical, and environmental factors contributing to maternal morbidity and mortality.",
"   </p>",
"   <p>",
"    For pregnant women, optimizing intrapartum care appears to be the single most important intervention for reducing maternal mortality in both high-income countries",
"    <span class=\"nowrap\">",
"     (HIC)/resource-rich",
"    </span>",
"    settings and",
"    <span class=\"nowrap\">",
"     middle/low-income",
"    </span>",
"    countries",
"    <span class=\"nowrap\">",
"     (MIC/LIC)/resource-limited",
"    </span>",
"    settings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The leading causes of mortality in these women are hemorrhage, hypertensive disorders, infection, obstructed labor, and complications from unsafe abortions. In LICs, major causal factors are inadequate prenatal, intrapartum, and postpartum care by skilled birth attendants and inadequate facilities, equipment, and services. For nonpregnant women, family planning is the single most important intervention for reducing maternal mortality.",
"   </p>",
"   <p>",
"    This topic will discuss approaches to reduction of maternal mortality in the poorest parts of the world. In these areas, dying as a result of pregnancy or childbirth is about 1 in 6 compared with about 1 in 30,000 in Northern Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/5\">",
"     5",
"    </a>",
"    ]. An overview of principles of maternal mortality, including strategies for reduction in high income countries, is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/59/40888?source=see_link\">",
"     \"Overview of maternal mortality\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9876362\">",
"    <span class=\"h1\">",
"     SERVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;One model suggested a stepwise approach that coupled improved family planning with incremental improvements in skilled attendance, transport, referral, facilities, and intrapartum care would prevent three of four maternal deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/6\">",
"     6",
"    </a>",
"    ]. These interventions are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21805121\">",
"    <span class=\"h2\">",
"     Family planning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family planning is one of the four pillars of the Safe Motherhood Initiative to reduce maternal death in developing countries, and may be the single most important intervention for achieving this goal. Family planning can reduce mortality in women in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduction in unwanted pregnancy, which",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Decreases pregnancy-related mortality",
"     </li>",
"     <li>",
"      Decreases abortion-related mortality",
"     </li>",
"     <li>",
"      Delays first pregnancy in adolescents. Pelvic development may be incomplete in adolescents, resulting in cephalopelvic disproportion. In nutritionally restricted environments, the nutritional requirements of growing adolescents appear to compete with the growth needs of the fetus, potentially resulting in stunting of both maternal and fetal growth [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reduces high parity, which is associated with an increased risk of life threatening complications such as placenta previa and postpartum hemorrhage (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17556?source=see_link\">",
"       \"Obstetrical issues in grand multiparity\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Reduces closely spaced pregnancies, allowing the mother to recover between pregnancies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Noncontraceptive health benefits (eg, reduction in ectopic pregnancy and some cancers) (",
"      <a class=\"graphic graphic_table graphicRef82147 \" href=\"UTD.htm?32/35/33339\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential benefit of contraception for averting maternal deaths worldwide was evaluated in a study that extracted data from the Maternal Mortality Estimation Inter-Agency Group database, the United Nations (UN) World Contraceptive Use 2010 database, and the UN World Population Prospects 2010 database [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/9\">",
"     9",
"    </a>",
"    ]. The model estimated that 342,203 women died of maternal causes in 2008, but that contraceptive use averted an additional 272,040 deaths (95% CI 127,937-407,134), thus use of contraception resulted in a 44 percent reduction in maternal death. The model also predicted that satisfying unmet needs for contraception could prevent another 104,000 maternal deaths per year (29 percent reduction). Another model also affirmed that promotion and facilitation of family planning should be the initial approach for reduction of maternal mortality in low-income countries (LICs) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unsafe abortion is another major cause of maternal death that ideally is averted by protection against unwanted pregnancy. In 2005, it was estimated that 70,000 women died yearly as a result of unsafe abortion, accounting for one in eight (13 percent) maternal deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/10\">",
"     10",
"    </a>",
"    ]. Almost all of these deaths occurred in Sub-Saharan Africa, South Central Asia, Latin America and the Caribbean, and some Eastern European countries; a negligible number occurred in Southern and Western Europe, North America and China. When unwanted pregnancy does occur, maternal death is rare where abortion is legal and access is nonrestrictive, and when pregnancy terminations are carried out by skilled health professionals using effective methods in hygienic conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link&amp;anchor=H29#H29\">",
"     \"Overview of pregnancy termination\", section on 'Maternal mortality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Short interpregnancy intervals also appear to increase the risk of maternal mortality, and can be avoided by use of contraception. A Latin American study including 456,889 women reported interpregnancy intervals of less than six months were associated with an increased risk of maternal death compared with women with interpregnancy intervals of 18 to 23 months (adjusted OR 2.5; 95% CI 1.2-5.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/12\">",
"     12",
"    </a>",
"    ]. Four smaller studies of variable quality also found an association between short interpregnancy interval and maternal death, but the trend was not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/63/13302?source=see_link\">",
"     \"Interpregnancy interval and pregnancy outcome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2777104\">",
"    <span class=\"h2\">",
"     Skilled birth attendants",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than two-thirds of women worldwide give birth at home, often with a traditional birth attendant who is not a trained health-care provider. The availability of a skilled attendant implies the presence of a health professional with midwifery skills, as well as resources to enable them to perform capably, including access to higher levels of obstetric care in case of complications requiring surgery or blood transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ensuring that all women give birth with a skilled attendant is considered one of the key strategies for reducing maternal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/3,15\">",
"     3,15",
"    </a>",
"    ]. As of 2010, most countries have achieved, are on track to making, or are making some progress toward a target of 80 percent of births attended by a skilled provider, but 14 countries have made insufficient progress and 11 have made no progress [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, evidence supporting the role of skilled attendants in the reduction of maternal mortality is primarily based on studies from high-income countries (HICs) and middle-income countries (MICs) with functioning health systems [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/3\">",
"     3",
"    </a>",
"    ]. Evidence that a skilled attendance strategy contributes to a reduction in maternal mortality in poor countries is sparse.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study from rural Bangladesh that compared maternal mortality ratio (MMR) in villages where trained midwives were posted and asked to attend as many home-deliveries as possible versus neighboring villages with comparable baseline MMR and no trained midwives, MMR became significantly lower in the intervention villages than in the control villages after three years",
"      <span class=\"nowrap\">",
"       (140/100,000",
"      </span>",
"      versus",
"      <span class=\"nowrap\">",
"       380/100,000",
"      </span>",
"      live births) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A review of 10 observational studies of the association between maternal mortality and birth with a health professional concluded that at the country level, there was a downward trend in maternal mortality with increasing proportions of births with skilled attendants, but at the individual level, there was little evidence of a benefit [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/18\">",
"       18",
"      </a>",
"      ]. The authors opined that case definitions, confounding, and selection issues need to be addressed before valid conclusions can be drawn. For example, in areas with poor access to skilled birth attendants, only the sickest women may seek this care and the attendants may have inadequate skills or resources to care for them.",
"     </li>",
"     <li>",
"      A systematic review and meta-analysis of the effectiveness of strategies incorporating providing training and support of traditional birth attendants showed a statistically non-significant reduction in maternal mortality (three randomized trials, RR 0.79, 95% CI 0.53-1.05; three non-randomized studies, RR 0.80, 95% CI 0.44-1.15) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another systematic review concluded that available studies were difficult to compare but interventions described in individual studies related to cost, transport, outreach-friendly drugs, and targeted training appeared promising for reduction of maternal mortality and morbidity in LICs [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Availability of skilled birth attendants alone will not reduce maternal mortality if they are not utilized [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In a study from Nigeria, which has a very high MMR",
"    <span class=\"nowrap\">",
"     (&gt;1000/100,000",
"    </span>",
"    live births in 2008), the reasons for low utilization of antenatal and delivery care among women with recent pregnancies were: custom, lack of perceived need, distance, lack of transport, lack of permission, cost,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    unwillingness to see a male doctor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/21\">",
"     21",
"    </a>",
"    ]. Therefore, when designing and implementing interventions to improve obstetrical care, women need to be educated about safe pregnancy and delivery, their economic and geographic accessibility issues need to be addressed, and their social and cultural beliefs and practices need to be respected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89738349\">",
"    <span class=\"h2\">",
"     Emergency obstetrical care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) considers the ability to provide the following seven &ldquo;basic&rdquo; services requisite for provision of emergency obstetric care [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Administer parenteral antibiotics",
"     </li>",
"     <li>",
"      Administer uterotonic drugs",
"     </li>",
"     <li>",
"      Administer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      to women with",
"      <span class=\"nowrap\">",
"       preeclampsia/eclampsia",
"      </span>",
"     </li>",
"     <li>",
"      Manually remove the placenta",
"     </li>",
"     <li>",
"      Remove retained products manually, with vacuum extraction, or by dilation and curettage",
"     </li>",
"     <li>",
"      Perform assisted vaginal delivery by vacuum extraction or forceps",
"     </li>",
"     <li>",
"      Perform basic neonatal resuscitation with a bag and mask",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &ldquo;Comprehensive&rdquo; services can provide the ability to perform surgery (eg, cesarean delivery) and blood transfusions, in addition to basic services.",
"   </p>",
"   <p>",
"    Access to surgical care can reduce maternal morbidity and mortality in women who require hysterectomy because of hemorrhage or who experience obstructed labor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/24\">",
"     24",
"    </a>",
"    ]. Cesarean delivery rates are an indirect measure of access to skilled providers and surgical facilities, equipment, and services. The WHO, the United Nations Children&rsquo;s Fund (UNICEF), and the United Nations Population Fund (UNFPA) cite a minimal cesarean delivery rate of 5 percent as evidence of adequate access to these resources [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both structural and organizational barriers (eg, cost, lack of vehicles for transport, lack of telephones, difficult geographical terrain) can prolong the time it takes a woman to reach an appropriate health care facility after a problem has been recognized and the decision has been made to refer her for emergency obstetrical care. Modeling techniques have predicted that a clinically important decline in maternal mortality requires access to emergency obstetric care, as well as other interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/25\">",
"     25",
"    </a>",
"    ]. Although intuitive, there is no high quality evidence to support this hypothesis or determine the optimal types of interventions. A systematic review of 19 studies of 14 interventions (eg, ambulances, maternity waiting homes) designed to overcome delays in receiving emergency obstetrical care in LICs found that the interventions studied significantly reduced neonatal mortality and appeared to decrease stillbirths, but did not clearly demonstrate a sustained reduction in maternal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/26\">",
"     26",
"    </a>",
"    ]. However, these results are difficult to interpret given the limitations of the studies, such as differences in the interventions and use of multiple interventions, differences in timing of the interventions, and lack of analysis of the effects of concurrent factors that affect maternal mortality. The authors concluded that an important goal of future research should be to understand how these interventions work and why.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89736658\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Availability of ultrasound examination is an essential element of emergency obstetric services in HICs and likely can play a role in reducing maternal morbidity and mortality in LICs by:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early identification of extrauterine pregnancy, which is an important factor for avoiding rupture and preventing ectopic pregnancy-related maternal death [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Antepartum identification of abnormal placentation (eg, placenta previa, placenta accreta), which enables cesarean delivery under optimal conditions",
"     </li>",
"     <li>",
"      Early identification of molar pregnancies, which may reduce the risk that the patient will develop severe hemorrhage, thyrotoxicosis, preeclampsia, or ovarian hyperstimulation syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obstetrical ultrasound is not widely available in LICs. However, the development of portable and relatively inexpensive ultrasound equipment (compact ultrasound) offers the possibility of more widespread use. Several ongoing studies have described the value and institution of ultrasound training and surveillance programs focused on emergency obstetrics and gynecology service provision [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Partners in Health has developed a free, online reference manual of ultrasound targeted for clinicians working in resource-limited settings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89736988\">",
"    <span class=\"h2\">",
"     Policies and infrastructure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Policies and infrastructure that have been identified to reduce maternal mortality include development of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Services organized to ensure that antenatal care is provided through facilities and outreach programs that are available, accessible, and acceptable to all women in the service area. The infrastructure and services should reach poor disadvantaged ethnic groups and populations in rural areas with unmet health needs. Critical elements of maternal care should be available at no cost to poor patients.",
"     </li>",
"     <li>",
"      National standards and local protocols for integrated antenatal care services, management of complications, and timely referral when needed",
"     </li>",
"     <li>",
"      Functioning referral systems (communications, ambulance)",
"     </li>",
"     <li>",
"      Integration of the provision of health care with provision of education, water, sanitation, and rural development",
"     </li>",
"     <li>",
"      Medical and nonmedical services providing continuity of childbirth and postnatal care",
"     </li>",
"     <li>",
"      Policies that address social, cultural, and financial factors that affect access to care and eliminate social, political, and environmental factors that adversely impact women and girls. A challenging aspect of global maternal mortality reduction is not directly related to medical services, but to eradication of poverty, inequity, gender-based violence, and exclusion of",
"      <span class=\"nowrap\">",
"       women/girls",
"      </span>",
"      from the resources they need to develop their full human potential (eg, education) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/37-44\">",
"       37-44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Systems for identification of disease-specific causes of maternal mortality and near miss maternal mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/45-48\">",
"       45-48",
"      </a>",
"      ], initiation of evidence-based interventions, and monitoring of outcomes. Processes for documenting, managing, and reporting data are needed for quality improvement and improved advocacy.",
"      <br/>",
"      <br/>",
"      In one study, continuous assessment, implementation, advocacy, outputs, and outcomes were associated with a 34 percent decrease in maternal mortality, and decreases in case fatality rates for preeclampsia (from 3.1 to 1.1 percent P&lt;0.05) and hemorrhage (from 14.8 to 1.9 percent P&lt;0.001) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/49\">",
"       49",
"      </a>",
"      ]. MMR decreased from",
"      <span class=\"nowrap\">",
"       496/100,000",
"      </span>",
"      live births in 2007 to",
"      <span class=\"nowrap\">",
"       328/100,000",
"      </span>",
"      in 2009.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89736614\">",
"    <span class=\"h1\">",
"     MEDICAL AND OBSTETRICAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leading medical and obstetrical causes of maternal death in the developing world are hemorrhage, hypertensive disorders, and sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16872072\">",
"    <span class=\"h2\">",
"     Peripartum hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhage is implicated in 25 percent of maternal deaths worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/50\">",
"     50",
"    </a>",
"    ] and is consistently one of the most common causes of maternal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approaches to prevention and treatment of hemorrhage that can be applied to both high- and low-resource settings include [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/53\">",
"     53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Active management of the third stage of labor",
"     </li>",
"     <li>",
"      Use of protocols or guidelines for management of hemorrhage",
"     </li>",
"     <li>",
"      Simulations or drills on management of hemorrhage for health providers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data from randomized trials and observational studies support the efficacy of these interventions for reducing the frequency and severity of peripartum hemorrhage, thus providing indirect evidence for a reduction in risk of maternal death due to hemorrhage. These data are reviewed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33114?source=see_link&amp;anchor=H32#H32\">",
"       \"Management of normal labor and delivery\", section on 'Active management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41639?source=see_link\">",
"       \"Uterotonic drugs for management of the third stage of labor\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1930?source=see_link&amp;anchor=H198030000#H198030000\">",
"       \"Reducing adverse obstetrical outcomes through safety sciences\", section on 'Postpartum hemorrhage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1930?source=see_link&amp;anchor=H16#H16\">",
"       \"Reducing adverse obstetrical outcomes through safety sciences\", section on 'Peripartum hemorrhage'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intravenous administration of oxytocin is the major component of active management of the third stage of labor and treatment of postpartum hemorrhage.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     Misoprostol",
"    </a>",
"    , a prostaglandin E1 analogue, is an alternative. Although randomized trials have shown that it is less effective than oxytocin for prevention of postpartum hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/54\">",
"     54",
"    </a>",
"    ], misoprostol is more effective than no treatment and it is inexpensive, easy to administer, and does not require refrigeration. Thus, use of misoprostol is advantageous in resource-poor countries where drugs that must be refrigerated or require needles for",
"    <span class=\"nowrap\">",
"     injection/intravenous",
"    </span>",
"    administration may pose a problem [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/55-63\">",
"     55-63",
"    </a>",
"    ]. We agree with World Health Organization (WHO) and International Federation of Gynecology and Obstetrics (FIGO",
"    <em>",
"     )",
"    </em>",
"    recommendations for its use for prevention of postpartum hemorrhage in low-resource settings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/53\">",
"     53",
"    </a>",
"    ]. It is also a reasonable approach for controlling blood loss in postpartum hemorrhage when oxytocin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/213?source=see_link\">",
"     ergonovine",
"    </a>",
"    is not available [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41929?source=see_link\">",
"     \"Management of postpartum hemorrhage at vaginal delivery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/44/27336?source=see_link\">",
"     \"Management of postpartum hemorrhage at cesarean delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16872079\">",
"    <span class=\"h2\">",
"     Preeclampsia/eclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia,",
"    </span>",
"    early detection and appropriate management prior to worsening maternal status are essential elements for reducing maternal mortality. The key interventions include [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/65\">",
"     65",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Antenatal care with periodic measurement of blood pressure",
"      </strong>",
"      . This prevents 70 percent of eclampsia by early detection of preeclampsia [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/66\">",
"       66",
"      </a>",
"      ]. Lack of antenatal care is associated with increased maternal",
"      <span class=\"nowrap\">",
"       morbidity/mortality",
"      </span>",
"      following eclampsia, independent of country of origin [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Intrapartum administration of",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      . The Magpie trial (magnesium sulphate for prevention of eclampsia) randomly assigned 10,141 preeclamptic women (85 percent from low-income countries [LIC] and middle-income countries [MIC] worldwide) to treatment with magnesium sulfate or placebo and demonstrated a 50 percent reduction of eclampsia in patients treated with magnesium sulfate [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/68\">",
"       68",
"      </a>",
"      ]. Although, the Magpie trial was not statistically powered to detect differences in maternal mortality, eclampsia is a known contributor to maternal deaths globally [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/69\">",
"       69",
"      </a>",
"      ]. The case fatality rates for eclampsia are as high as 3 to 5 percent in LICs and MICs, and 1 percent in high-income countries (HICs). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/23/21882?source=see_link&amp;anchor=H16#H16\">",
"       \"Preeclampsia: Management and prognosis\", section on 'Seizure prophylaxis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39801?source=see_link&amp;anchor=H12#H12\">",
"       \"Eclampsia\", section on 'Treatment of convulsions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Administration of antihypertensive therapy",
"      </strong>",
"      . Controlling severe hypertension reduces the risk of stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/70,71\">",
"       70,71",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13434?source=see_link&amp;anchor=H4#H4\">",
"       \"Management of hypertension in pregnant and postpartum women\", section on 'Indications for antihypertensive therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Delivery",
"      </strong>",
"      . Delivery of the placenta always results in complete resolution of signs and symptoms of",
"      <span class=\"nowrap\">",
"       preeclampsia/eclampsia",
"      </span>",
"      and is the only curative intervention. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=see_link&amp;anchor=H1566744#H1566744\">",
"       \"Preeclampsia: Clinical features and diagnosis\", section on 'Course'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/23/21882?source=see_link&amp;anchor=H31268781#H31268781\">",
"       \"Preeclampsia: Management and prognosis\", section on 'Overview of management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2405059\">",
"    <span class=\"h3\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few interventions are highly effective for preventing preeclampsia. Given the limited resources of LICs and the no more than modest impact of these interventions, we suggest available resources be applied to management rather than prevention of preeclampsia.",
"   </p>",
"   <p>",
"    In randomized trials of women at moderate to high risk of developing the disorder, low dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    had a modest impact in reducing the risk of preeclampsia, as well as other adverse pregnancy outcomes (eg, preterm delivery, fetal growth restriction). These data are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41609?source=see_link&amp;anchor=H2#H2\">",
"     \"Prevention of preeclampsia\", section on 'Antiplatelet agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data from meta-analysis of randomized trials also show that calcium supplementation during pregnancy significantly reduced the risk of developing preeclampsia, especially in women at high risk of developing the disease (five trials, 587 women: RR 0.22, 95% CI 0.12-0.42) or low baseline calcium intake (eight trials, 10,678 women: RR 0.36, 95% CI 0.20-0.65) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/72\">",
"     72",
"    </a>",
"    ]. Maternal mortality was also reduced, but the number of deaths was small (n = 7) and the reduction did not reach statistical significance (RR 0.17, 95% CI 0.02-1.39). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41609?source=see_link&amp;anchor=H12#H12\">",
"     \"Prevention of preeclampsia\", section on 'Calcium supplementation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16872086\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of life-threatening pregnancy-related infection in LICs and MICs are due to puerperal sepsis (eg, chorioamnionitis, endometritis),",
"    <span class=\"nowrap\">",
"     pyelonephritis/urosepsis,",
"    </span>",
"    septic abortion, or skin and soft tissue infection (eg, necrotizing fasciitis, abscess, cellulitis, myonecrosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89736995\">",
"    <span class=\"h3\">",
"     Bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Problems related to infection control in developing countries include poor antibiotic prescribing practices, poorly functioning laboratory services, lack of surveillance data, sub-optimal design or construction of buildings and water and sanitation systems, overcrowding of facilities, insufficient numbers of trained health workers, and insufficient understanding of basic infection control issues [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sepsis is responsible for 2 percent of maternal deaths in the United States and other HICs, but results in 10 to 12 percent of deaths in LICs and MICs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/75\">",
"     75",
"    </a>",
"    ]. Most of these deaths are due to postpartum bacterial infection, which can be reduced by timely use of antibiotics according to established protocols.",
"   </p>",
"   <p>",
"    The concept that puerperal sepsis can be prevented by improved hygiene dates back to Ignaz Semmelweiss (1818-1865) and Oliver Wendell Holmes (1809-1894). In order to reduce the risk of puerperal bacterial infection in low-resource areas, WHO promotes the observance of &ldquo;six cleans&rdquo; at the time of delivery: clean hands, clean perineum, clean delivery surface, clean cord and tying instruments, and clean cutting surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/76\">",
"     76",
"    </a>",
"    ]. This is best achieved through use of clean delivery kits, which are associated with a reduction in maternal and neonatal sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Most kits contain a small bar of soap for washing hands, a plastic sheet to use as the delivery surface, clean gloves, clean string for tying the umbilical cord, a new razor blade or scalpel for cutting the cord, and pictorial instructions that illustrate the sequence of delivery events and hand-washing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89737002\">",
"    <span class=\"h3\">",
"     Viruses and parasites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses and parasites also contribute to infection-related maternal death. Influenza-associated mortality appears to be higher in pregnant women than in nonpregnant women. Data from observational studies suggest that public health measures, such as vaccination and use of antiviral drugs, reduce this risk. These data are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35224?source=see_link\">",
"     \"Influenza and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89737009\">",
"    <span class=\"h4\">",
"     HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;While maternal mortalities related to the human immunodeficiency virus",
"    <span class=\"nowrap\">",
"     (HIV)/acquired",
"    </span>",
"    immune deficiency syndrome (AIDS) are now rare in HICs where access to appropriate therapies is available,",
"    <span class=\"nowrap\">",
"     HIV/AIDs",
"    </span>",
"    contributes to the high maternal mortality rates in Sub-Saharan Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. Maternal",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    is associated with an increased risk of maternal death from endometritis, pneumonia, tuberculosis, and malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25290?source=see_link\">",
"     \"Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/23/29050?source=see_link\">",
"     \"Prevention of HIV transmission during breastfeeding in resource-limited settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89737016\">",
"    <span class=\"h4\">",
"     Malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaria is a major cause of maternal death in endemic areas, even in the absence of HIV infection. Prevention involves chemoprophylaxis and mosquito avoidance; treatment consists of antimalarial therapy and supportive care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/33/16921?source=see_link\">",
"     \"Overview of malaria in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20695?source=see_link\">",
"     \"Treatment and prevention of malaria in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89737114\">",
"    <span class=\"h1\">",
"     WORLD HEALTH ORGANIZATION RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) provides written descriptions of the key effective interventions for maternity and newborn care for use by communities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    facilities in developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/83-85\">",
"     83-85",
"    </a>",
"    ]. These recommendations include access to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family planning services",
"     </li>",
"     <li>",
"      Safe abortion services",
"     </li>",
"     <li>",
"      Emergency obstetric care (EMOC)",
"     </li>",
"     <li>",
"      Essential preventive and promotive care in pregnancy, including prevention of mother to child transmission of human immunodeficiency virus (HIV), and the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Nationally agreed standards and local protocols for integrated antenatal care services and timely referral and management of complications",
"     </li>",
"     <li>",
"      Policies that address social, cultural, and financial factors that affect access to care",
"     </li>",
"     <li>",
"      Services organized to ensure that antenatal care is provided through facilities and outreach programs that are available, accessible and acceptable to all women in the service area",
"     </li>",
"     <li>",
"      Services linked to a health care system providing continuity with childbirth and postnatal care",
"     </li>",
"     <li>",
"      Skilled health professionals",
"     </li>",
"     <li>",
"      Essential medicines and medical devices",
"     </li>",
"     <li>",
"      Functioning referral system (communications, ambulance)",
"     </li>",
"     <li>",
"      Adequate recording and reporting systems",
"     </li>",
"     <li>",
"      Use of data for quality improvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89737132\">",
"    <span class=\"h1\">",
"     EXAMPLES OF SUCCESSFUL INTERVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaysia and Sri Lanka reduced their very high maternal mortality ratio (MMR) over a period of four decades, despite low per capita incomes (half of the population is below the poverty line) and high illiteracy rates for women when these programs were initiated. Malaysia reduced MMR from",
"    <span class=\"nowrap\">",
"     534/100,000",
"    </span>",
"    live births in 1950 to",
"    <span class=\"nowrap\">",
"     18/100,000",
"    </span>",
"    live births in 1991; Sri Lanka reduced MMR from",
"    <span class=\"nowrap\">",
"     1056/100,000",
"    </span>",
"    live births in 1947 to",
"    <span class=\"nowrap\">",
"     27/100,000",
"    </span>",
"    live births in 1992 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28761/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These reductions were achieved with relatively low expenditures on maternal health: 0.2 to 0.3 percent of the gross domestic product. Review of the amount of time it took these countries to halve their MMR suggests that, once a country reaches a maternal mortality ratio of",
"    <span class=\"nowrap\">",
"     200/100,000",
"    </span>",
"    live births, it can further halve maternal mortality in 7 to 10 years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89738266\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The leading causes of maternal mortality in pregnant women are hemorrhage, hypertensive disorders, infection, obstructed labor, and complications from unsafe abortions. (See",
"      <a class=\"local\" href=\"#H16872044\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Availability of free, accessible family planning appears to be a key factor in reducing maternal mortality. Reduction in unwanted pregnancy reduces pregnancy-related mortality and abortion-related mortality. (See",
"      <a class=\"local\" href=\"#H21805121\">",
"       'Family planning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The availability of skilled birth attendants and resources for emergency obstetrical care are major goals for reducing intrapartum and postpartum mortality. (See",
"      <a class=\"local\" href=\"#H2777104\">",
"       'Skilled birth attendants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H89738349\">",
"       'Emergency obstetrical care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For prevention of postpartum hemorrhage,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      is less effective than oxytocin, but more effective than no treatment. However, it is a reasonable option in resource-poor countries where drugs that must be refrigerated or require needles for",
"      <span class=\"nowrap\">",
"       injection/intravenous",
"      </span>",
"      administration may pose a problem. It is also a reasonable approach for controlling blood loss in postpartum hemorrhage when oxytocin or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/213?source=see_link\">",
"       ergonovine",
"      </a>",
"      is not available. (See",
"      <a class=\"local\" href=\"#H16872072\">",
"       'Peripartum hemorrhage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antenatal care with periodic measurement of blood pressure potentially prevents 70 percent of eclampsia by early detection of preeclampsia. Case fatality rates for eclampsia are as high as 3 to 5 percent in low-income countries (LICs). Additional key interventions for reduction of maternal morbidity and mortality include administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      and antihypertensive therapy of severe hypertension. (See",
"      <a class=\"local\" href=\"#H16872079\">",
"       'Preeclampsia/eclampsia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We agree with World Health Organization (WHO) recommendations for observance of &ldquo;six cleans&rdquo; at the time of delivery: clean hands, clean perineum, clean delivery surface, clean cord and tying instruments, and clean cutting surfaces (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Use of a clean delivery kit reduces maternal and neonatal sepsis. (See",
"      <a class=\"local\" href=\"#H89736995\">",
"       'Bacterial infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.un.org/millenniumgoals/bkgd.shtml (Accessed on July 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/2\">",
"      Bhutta ZA, Chopra M, Axelson H, et al. Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet 2010; 375:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/3\">",
"      Campbell OM, Graham WJ, Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006; 368:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/4\">",
"      Tita AT, Stringer JS, Goldenberg RL, Rouse DJ. Two decades of the safe motherhood initiative: time for another wooden spoon award? Obstet Gynecol 2007; 110:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/5\">",
"      Ronsmans C, Graham WJ, Lancet Maternal Survival Series steering group. Maternal mortality: who, when, where, and why. Lancet 2006; 368:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/6\">",
"      Carvalho N, Salehi AS, Goldie SJ. National and sub-national analysis of the health benefits and cost-effectiveness of strategies to reduce maternal mortality in Afghanistan. Health Policy Plan 2013; 28:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/7\">",
"      Rah JH, Christian P, Shamim AA, et al. Pregnancy and lactation hinder growth and nutritional status of adolescent girls in rural Bangladesh. J Nutr 2008; 138:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/8\">",
"      Shirima CP, Kinabo JL. Nutritional status and birth outcomes of adolescent pregnant girls in Morogoro, Coast, and Dar es Salaam regions, Tanzania. Nutrition 2005; 21:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/9\">",
"      Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 2012; 380:111.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. Abortion Worldwide: A decade of uneven progress. file://www.guttmacher.org/pubs/Abortion-Worldwide.pdf (Accessed on July 12, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/11\">",
"      Singh K, Ratnam SS. The influence of abortion legislation on maternal mortality. Int J Gynaecol Obstet 1998; 63 Suppl 1:S123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/12\">",
"      Conde-Agudelo A, Beliz&aacute;n JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000; 321:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/13\">",
"      Conde-Agudelo A, Rosas-Berm&uacute;dez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol 2007; 196:297.",
"     </a>",
"    </li>",
"    <li>",
"     Grahm WJ, Bell J, and Bullough C. Can skilled attendance at delivery reduce maternal mortality in developing countries. In: Safe Motherhood Strategies: A Review of the Evidence (eds V De Brouwere &amp; W van Lerberghe). 2001. ITG Press, Antwerp,",
"pp. 97&ndash;130.",
"    </li>",
"    <li>",
"     WHO, ICM, and FIGO. Making pregnancy safer: The critical role of the skilled attendant. WHO, Geneva 2004.",
"    </li>",
"    <li>",
"     Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates www.unfpa.org/webdav/.../Trends_in_maternal_mortality_A4-1.pdf (Accessed on July 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/17\">",
"      Fauveau V, Stewart K, Khan SA, Chakraborty J. Effect on mortality of community-based maternity-care programme in rural Bangladesh. Lancet 1991; 338:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/18\">",
"      Scott S, Ronsmans C. The relationship between birth with a health professional and maternal mortality in observational studies: a review of the literature. Trop Med Int Health 2009; 14:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/19\">",
"      Wilson A, Gallos ID, Plana N, et al. Effectiveness of strategies incorporating training and support of traditional birth attendants on perinatal and maternal mortality: meta-analysis. BMJ 2011; 343:d7102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/20\">",
"      Pyone T, Sorensen BL, Tellier S. Childbirth attendance strategies and their impact on maternal mortality and morbidity in low-income settings: a systematic review. Acta Obstet Gynecol Scand 2012; 91:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/21\">",
"      Doctor HV, Findley SE, Ager A, et al. Using community-based research to shape the design and delivery of maternal health services in Northern Nigeria. Reprod Health Matters 2012; 20:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/22\">",
"      Oyerinde K, Harding Y, Amara P, et al. A Qualitative Evaluation of the Choice of Traditional Birth Attendants for Maternity Care in 2008 Sierra Leone: Implications for Universal Skilled Attendance at Delivery. Matern Child Health J 2012.",
"     </a>",
"    </li>",
"    <li>",
"     Monitoring Obstetric Care: a handbook whqlibdoc.who.int/publications/2009/9789241547734_eng.pdf (Accessed on July 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/24\">",
"      AbouZahr C, Wardlaw T. Maternal mortality at the end of a decade: signs of progress? Bull World Health Organ 2001; 79:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/25\">",
"      Goldie SJ, Sweet S, Carvalho N, et al. Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysis. PLoS Med 2010; 7:e1000264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/26\">",
"      Hussein J, Kanguru L, Astin M, Munjanja S. The effectiveness of emergency obstetric referral interventions in developing country settings: a systematic review. PLoS Med 2012; 9:e1001264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/27\">",
"      Sy T, Diallo Y, Toure A, et al. [Management of ectopic pregnancy in Conakry, Guinea]. Med Trop (Mars) 2009; 69:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/28\">",
"      Nayama M, Gallais A, Ousmane N, et al. [Management of ectopic pregnancy in developing countries: example of a Nigerian reference maternity]. Gynecol Obstet Fertil 2006; 34:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/29\">",
"      Shah SP, Epino H, Bukhman G, et al. Impact of the introduction of ultrasound services in a limited resource setting: rural Rwanda 2008. BMC Int Health Hum Rights 2009; 9:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/30\">",
"      Harris RD, Marks WM. Compact ultrasound for improving maternal and perinatal care in low-resource settings: review of the potential benefits, implementation challenges, and public health issues. J Ultrasound Med 2009; 28:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/31\">",
"      Kimberly HH, Murray A, Mennicke M, et al. Focused maternal ultrasound by midwives in rural Zambia. Ultrasound Med Biol 2010; 36:1267.",
"     </a>",
"    </li>",
"    <li>",
"     Shah S, Price. Manual of Ultrasound for Resource&mdash;Limited Settings 2011. Partners in Health. file://www.pih.org/publications/entry/manual-of-ultrasound-for-resource-limited-settings (Accessed on June 22, 2012).",
"    </li>",
"    <li>",
"     Pathmanathan I, Liljestrand J, Martins JM. Investing in maternal health. Learning from Malaysia and Sri Lanka. World Bank, Washington, DC 2003.",
"    </li>",
"    <li>",
"     Koblinsky M ed. Reducing maternal morality: learning from Bolivia, China, Egypt, Honduras, Indonesia, Jamaica, and Zimbabwe. World Bank, Washington DC 2003.",
"    </li>",
"    <li>",
"     Packages of Interventions for Family Planning, Safe Abortion care, Maternal, Newborn and Child Health. file://whqlibdoc.who.int/hq/2010/WHO_FCH_10.06_eng.pdf (Accessed on March 22, 2011).",
"    </li>",
"    <li>",
"     WHO Technical consultation on postpartum and postnatal care. file://www.who.int/making_pregnancy_safer/documents/WHO_MPS_10_03/en/index.html (Accessed on March 22, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/37\">",
"      Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/38\">",
"      Amowitz LL, Kim G, Reis C, et al. Human rights abuses and concerns about women's health and human rights in southern Iraq. JAMA 2004; 291:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/39\">",
"      Amowitz LL, Reis C, Iacopino V. Maternal mortality in Herat Province, Afghanistan, in 2002: an indicator of women's human rights. JAMA 2002; 288:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/40\">",
"      Swiss S, Jennings PJ, Aryee GV, et al. Violence against women during the Liberian civil conflict. JAMA 1998; 279:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/41\">",
"      Nour NN. Maternal health considerations during disaster relief. Rev Obstet Gynecol 2011; 4:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/42\">",
"      Amowitz LL, Reis C, Lyons KH, et al. Prevalence of war-related sexual violence and other human rights abuses among internally displaced persons in Sierra Leone. JAMA 2002; 287:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/43\">",
"      Mukherjee JS, Barry DJ, Satti H, et al. Structural violence: a barrier to achieving the millennium development goals for women. J Womens Health (Larchmt) 2011; 20:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/44\">",
"      Cook RJ, Dickens BM. Human rights to safe motherhood. Int J Gynaecol Obstet 2002; 76:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/45\">",
"      Say L, Pattinson RC, G&uuml;lmezoglu AM. WHO systematic review of maternal morbidity and mortality: the prevalence of severe acute maternal morbidity (near miss). Reprod Health 2004; 1:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/46\">",
"      Filippi V, Brugha R, Browne E, et al. Obstetric audit in resource-poor settings: lessons from a multi-country project auditing 'near miss' obstetrical emergencies. Health Policy Plan 2004; 19:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/47\">",
"      Filippi V, Ganaba R, Baggaley RF, et al. Health of women after severe obstetric complications in Burkina Faso: a longitudinal study. Lancet 2007; 370:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/48\">",
"      Weeks A, Lavender T, Nazziwa E, Mirembe F. Personal accounts of 'near-miss' maternal mortalities in Kampala, Uganda. BJOG 2005; 112:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/49\">",
"      Srofenyoh E, Ivester T, Engmann C, et al. Advancing obstetric and neonatal care in a regional hospital in Ghana via continuous quality improvement. Int J Gynaecol Obstet 2012; 116:17.",
"     </a>",
"    </li>",
"    <li>",
"     Bayer A. Population Resource Center. January 2001 www.prcdc.org/files/Maternal_Mortality.pdf (Accessed on July 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/51\">",
"      Cristina Rossi A, Mullin P. The etiology of maternal mortality in developed countries: a systematic review of literature. Arch Gynecol Obstet 2012; 285:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/52\">",
"      Coyaji BJ. Maternal mortality and morbidity in the developing countries like India. Indian J Matern Child Health 1991; 2:3.",
"     </a>",
"    </li>",
"    <li>",
"     WHO, ICM, FIGO. Making pregnancy safer: the critical role of the skilled attendant. Geneva: WHO, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/54\">",
"      Tun&ccedil;alp &Ouml;, Hofmeyr GJ, G&uuml;lmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012; 8:CD000494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/55\">",
"      Pagel C, Lewycka S, Colbourn T, et al. Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet 2009; 374:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/56\">",
"      Tsu VD, Langer A, Aldrich T. Postpartum hemorrhage in developing countries: is the public health community using the right tools? Int J Gynaecol Obstet 2004; 85 Suppl 1:S42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/57\">",
"      Lokugamage AU, Sullivan KR, Niculescu I, et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand 2001; 80:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/58\">",
"      Calikan E, Meydanli MM, Dilbaz B, et al. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 2002; 187:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/59\">",
"      H&oslash;j L, Cardoso P, Nielsen BB, et al. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005; 331:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/60\">",
"      Enakpene CA, Morhason-Bello IO, Enakpene EO, et al. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor. J Obstet Gynaecol Res 2007; 33:810.",
"     </a>",
"    </li>",
"    <li>",
"     Parsons, SM, Walley, RL, Crane, JM, Matthews, K, Hutchens, D. Rectal misoprostol versus oxytocin in the management of the third stage of labour.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/62\">",
"      Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006; 368:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/63\">",
"      Mobeen N, Durocher J, Zuberi N, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 2011; 118:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/64\">",
"      Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007; :CD003249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/65\">",
"      Goldenberg RL, McClure EM, Macguire ER, et al. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet 2011; 113:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/66\">",
"      Carroli G, Rooney C, Villar J. How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence. Paediatr Perinat Epidemiol 2001; 15 Suppl 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/67\">",
"      MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/68\">",
"      Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/69\">",
"      Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33:130.",
"     </a>",
"    </li>",
"    <li>",
"     Working group report on high blood pressure in pregnancy. National Institutes of Health, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/71\">",
"      Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/72\">",
"      Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010; :CD001059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/73\">",
"      Gravett CA, Gravett MG, Martin ET, et al. Serious and life-threatening pregnancy-related infections: opportunities to reduce the global burden. PLoS Med 2012; 9:e1001324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/74\">",
"      Hussein J, Mavalankar DV, Sharma S, D'Ambruoso L. A review of health system infection control measures in developing countries: what can be learned to reduce maternal mortality. Global Health 2011; 7:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/75\">",
"      Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:1066.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Essential newborn care: report of a technical working group. 1994 file://helid.digicollection.org/es/d/Js2892e/ (Accessed on July 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/77\">",
"      Darmstadt GL, Hassan M, Balsara ZP, et al. Impact of clean delivery-kit use on newborn umbilical cord and maternal puerperal infections in Egypt. J Health Popul Nutr 2009; 27:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/78\">",
"      Winani S, Wood S, Coffey P, et al. Use of a clean delivery kit and factors associated with cord infection and puerperal sepsis in Mwanza, Tanzania. J Midwifery Womens Health 2007; 52:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/79\">",
"      Mosha F, Winani S, Wood S, et al. Evaluation of the effectiveness of a clean delivery kit intervention in preventing cord infection and puerperal sepsis among neonates and their mothers in rural Mwanza Region, Tanzania. Tanzan Health Res Bull 2005; 7:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/80\">",
"      Le Coeur S, Khlat M, Halembokaka G, et al. HIV and the magnitude of pregnancy-related mortality in Pointe Noire, Congo. AIDS 2005; 19:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/81\">",
"      Bicego G, Boerma JT, Ronsmans C. The effect of AIDS on maternal mortality in Malawi and Zimbabwe. AIDS 2002; 16:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28761/abstract/82\">",
"      van den Akker T, de Vroome S, Mwagomba B, et al. Peripartum infections and associated maternal mortality in rural Malawi. Obstet Gynecol 2011; 118:266.",
"     </a>",
"    </li>",
"    <li>",
"     Packages of Interventions for Family Planning, Safe Abortion care, Maternal, Newborn and Child Health. file://whqlibdoc.who.int/hq/2010/WHO_FCH_10.06_eng.pdf (Accessed on June 22, 2012).",
"    </li>",
"    <li>",
"     WHO Technical consultation on postpartum and postnatal care. file://www.who.int/making_pregnancy_safer/documents/WHO_MPS_10_03/en/index.html (Accessed on June 22, 2012).",
"    </li>",
"    <li>",
"     World Health Organization. Monitoring Emergency Obstetric Care: a handbook. 2009. file://www.unfpa.org/public/publications/pid/3073 (Accessed on July 19, 2012).",
"    </li>",
"    <li>",
"     Sri Lanka Department of Census and Statistics and Malaysia Department of Statistics",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16688 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-125.39.66.146-3A500C5829-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28761=[""].join("\n");
var outline_f28_5_28761=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H89738266\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16872044\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9876362\">",
"      SERVICES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21805121\">",
"      Family planning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2777104\">",
"      Skilled birth attendants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89738349\">",
"      Emergency obstetrical care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89736658\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H89736988\">",
"      Policies and infrastructure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89736614\">",
"      MEDICAL AND OBSTETRICAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16872072\">",
"      Peripartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16872079\">",
"      Preeclampsia/eclampsia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2405059\">",
"      - Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16872086\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H89736995\">",
"      - Bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H89737002\">",
"      - Viruses and parasites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H89737009\">",
"      HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H89737016\">",
"      Malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89737114\">",
"      WORLD HEALTH ORGANIZATION RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89737132\">",
"      EXAMPLES OF SUCCESSFUL INTERVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89738266\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/16688\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/16688|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/35/33339\" title=\"table 1\">",
"      Noncontraceptive benefits",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39801?source=related_link\">",
"      Eclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35224?source=related_link\">",
"      Influenza and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/63/13302?source=related_link\">",
"      Interpregnancy interval and pregnancy outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33114?source=related_link\">",
"      Management of normal labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/44/27336?source=related_link\">",
"      Management of postpartum hemorrhage at cesarean delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41929?source=related_link\">",
"      Management of postpartum hemorrhage at vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17556?source=related_link\">",
"      Obstetrical issues in grand multiparity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/33/16921?source=related_link\">",
"      Overview of malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/59/40888?source=related_link\">",
"      Overview of maternal mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=related_link\">",
"      Overview of pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/23/21882?source=related_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/23/29050?source=related_link\">",
"      Prevention of HIV transmission during breastfeeding in resource-limited settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41609?source=related_link\">",
"      Prevention of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1930?source=related_link\">",
"      Reducing adverse obstetrical outcomes through safety sciences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20695?source=related_link\">",
"      Treatment and prevention of malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25290?source=related_link\">",
"      Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41639?source=related_link\">",
"      Uterotonic drugs for management of the third stage of labor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_5_28762="Medical care of the returning veteran";
var content_f28_5_28762=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medical care of the returning veteran",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Michael J Roy, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Jeremy G Perkins, LTC, MD FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/5/28762/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/5/28762/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3796084\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nature of war-related injuries has changed considerably over time. Preventive measures, ranging from improved infection control to protective gear, have been effective in reducing military morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, the rapidity of evacuation and access to higher quality care have markedly improved survival rates for battle injuries. Clinicians caring for the new generation of combat veterans from wars in Afghanistan and Iraq need to be prepared for a different distribution of injuries than from prior wars. As an example, it is more common to see survivors of traumatic brain injury and amputees who have lost multiple limbs (as the torso is often spared by body armor).",
"   </p>",
"   <p>",
"    Despite the evolution of war-related injuries over time, there are three aspects of injuries that have not changed for the returning veteran. First, while non-combat injuries (eg, infections, gastrointestinal illness, and musculoskeletal problems not related to battle) have decreased dramatically in recent conflicts, they invariably outnumber combat-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/3\">",
"     3",
"    </a>",
"    ]. Second, the psychological effects of war are greater in number and duration than the physical effects over the long-term. Third, complaints in veterans presenting for care after deployment tend to be similar in distribution and frequency to those in the general primary care population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/4\">",
"     4",
"    </a>",
"    ]. Although the overall medical care of the returning veteran may be similar to that of the general population, there are certain issues (eg, traumatic brain injury, psychological sequelae, readjustment to society following deployment) that are of particular relevance to veterans.",
"   </p>",
"   <p>",
"    This topic will provide an overview of medical conditions commonly encountered in returning veterans, with a particular emphasis on US veterans returning from Afghanistan and Iraq. Specific medical conditions associated with combat are discussed in further detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=see_link\">",
"     \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39062?source=see_link\">",
"     \"Traumatic brain injury: Epidemiology, classification, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796170\">",
"    <span class=\"h1\">",
"     PHYSICAL INJURY DUE TO COMBAT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of combat-related fatalities has decreased over recent wars. This can be attributed to the use of tourniquets, modern body armor, rapid evacuation, early limb salvage, and improved hemostatic resuscitation practices [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/1,5,6\">",
"     1,5,6",
"    </a>",
"    ]. Soldiers with combat injuries, which may have been fatal in previous conflicts, are arriving to military treatment facilities in better physical condition and are able to receive higher quality care.",
"   </p>",
"   <p>",
"    There are clear differences between military and civilian trauma populations. Whereas blunt trauma, primarily due to motor vehicle accidents and falls, represents the most common injury among civilians in the United States (US), penetrating injuries are more common in combat casualties [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/7\">",
"     7",
"    </a>",
"    ]. The most common causes of serious penetrating injuries in civilian trauma centers are stabbings and low-velocity gunshot wounds, whereas in the military they tend to be high-velocity gunshot wounds and high-energy explosive munitions including improvised explosive devices (IEDs), mortars, and rockets which can produce varied fragmentation, concussive blast, and thermal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796184\">",
"    <span class=\"h2\">",
"     Amputations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review of 8,056 military casualties in Afghanistan and Iraq found that more than 70 percent were due to major limb injuries severe enough to either result in evacuation from combat or to prevent return to duty within 72 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/9\">",
"     9",
"    </a>",
"    ]. Some form of explosive device was involved with 88 percent of these injuries. Major injury resulted in amputations proximal to the wrist or ankle in 7.4 percent, compared to 8.3 percent in the Vietnam War, although service members are currently able to survive more serious injuries than in prior wars.",
"   </p>",
"   <p>",
"    Amputee care and the quality of prostheses have improved dramatically as a result of efforts to provide combat amputees with maximum function and mobility. Amputees are able to remain on active duty in the military after injuries that they may not have survived in prior wars. Functional capacity assessment can be helpful in determining whether an amputee is able to return to their usual home and work environment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/10\">",
"     10",
"    </a>",
"    ]. This is usually performed in conjunction with physical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    occupational therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22873?source=see_link\">",
"     \"Disability assessment and determination in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Phantom limb pain is a common symptom following amputations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/11\">",
"     11",
"    </a>",
"    ]. This may require chronic pain management, including referral to a pain specialist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40296?source=see_link\">",
"     \"Evaluation of chronic pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796191\">",
"    <span class=\"h2\">",
"     Traumatic brain injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic brain injury (TBI) is an important cause of disability among returning veterans. Traumatic brain injury (TBI) encompasses a broad range of pathologic injuries to the brain of varying clinical severity that result from head trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39062?source=see_link\">",
"     \"Traumatic brain injury: Epidemiology, classification, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While there is not complete agreement regarding classification, TBI may be best characterized by a combination of the Glasgow Coma Scale score (",
"    <a class=\"graphic graphic_table graphicRef81854 \" href=\"UTD.htm?28/62/29676\">",
"     table 1",
"    </a>",
"    ), duration of loss of consciousness, and clearly abnormal CT or MRI of the brain. Based on these criteria, as many as 99 percent of service members diagnosed with TBI have mild TBI, including transient or no loss of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/12\">",
"     12",
"    </a>",
"    ]. Mild TBI is difficult to distinguish from other conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/13\">",
"     13",
"    </a>",
"    ], since those who present for medical care often complain of memory difficulties, concentration impairment, irritability, and headaches, which are also common symptoms in conditions such as posttraumatic stress disorder (PTSD) and depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29626?source=see_link\">",
"     \"Concussion and mild traumatic brain injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TBI is a diagnosis given at the time of injury, based upon the circumstances of the inciting event, whereas persistent symptoms that may follow mild TBI are described as a postconcussion syndrome. The most common complaints of postconcussion syndrome include headache, dizziness, cognitive impairment, and psychological symptoms. Most patients recover quickly from postconcussion syndrome (within several weeks), although a minority have prolonged disability. A brain MRI should be performed to exclude other causes if there are persistent and disabling complaints. In the absence of a defined specific treatment for postconcussion syndrome, symptomatic treatment should be offered, which may include migraine medications, analgesics, psychological counseling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    psychotropic medications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=see_link\">",
"     \"Postconcussion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Moderate to severe TBI represents only a small fraction of those returning from the wars. Moderate to severe TBI usually requires aggressive management and may lead to long-term disability and cognitive dysfunction. A multicenter prospective double-blind, randomized, placebo-controlled trial identified that the N-methyl-d-aspartate antagonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    produced more rapid recovery of neurologic function during the four-week treatment period [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/14\">",
"     14",
"    </a>",
"    ]. However, the placebo group did show improvement during an ensuing two-week follow-up period, so that the two groups had similar functional status after six weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H617393371\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal cord, penetrating abdominal, and chest injuries are less common than in prior wars, likely due to body armor protecting the trunk and back [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/15\">",
"     15",
"    </a>",
"    ]. As mentioned above, limb and head trauma are the most common types of injuries in recent wars. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37642?source=see_link\">",
"     \"Chronic complications of spinal cord injury\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H3796184\">",
"     'Amputations'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H3796191\">",
"     'Traumatic brain injury'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796198\">",
"    <span class=\"h1\">",
"     PSYCHOLOGICAL SEQUELAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cohort study of 289,328 US veterans of the Iraq and Afghanistan Wars who received healthcare through the Veterans Administration between 2002 and 2008 showed that the overall prevalences of newly-diagnosed posttraumatic stress disorder (PTSD) and depression were 21.8 percent and 17.0 percent respectively, with rates increasing over that time period [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/16\">",
"     16",
"    </a>",
"    ]. However, these data are not necessarily representative of the overall postdeployment population, as a variety of biases may lead some to seek care from the VA. Associated mental and cognitive conditions from the wars in Afghanistan and Iraq are estimated to cost more than 600 billion US dollars.",
"   </p>",
"   <p>",
"    Screening for PTSD, depression, and anxiety disorders is important on return from deployment (",
"    <a class=\"graphic graphic_form graphicRef65285 \" href=\"UTD.htm?13/7/13429\">",
"     form 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77755 \" href=\"UTD.htm?31/30/32236\">",
"     table 3",
"    </a>",
"    ). However, an initial screening will miss most cases of mental health problems, and repeated screening is necessary, especially between 3 and 12 months after return [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of veterans who screen positive for a mental health disorder, less than half seek mental health care [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/19\">",
"     19",
"    </a>",
"    ]. There is no evidence to suggest that most available treatments for PTSD, depression, and anxiety disorders are more or less effective in military service members than in civilians. Multidisciplinary suicide prevention programs designed for injured returning veterans may reduce the number of suicides related to combat-related injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/20\">",
"     20",
"    </a>",
"    ]. The psychological sequelae of combat are important by themselves, but are also associated with increased rates of cardiovascular risk factors such as obesity, dyslipidemia, tobacco use, and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H341622647\">",
"    <span class=\"h2\">",
"     Posttraumatic stress disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTSD is characterized by intrusive thoughts, nightmares, and flashbacks of past traumatic events, avoidance of reminders of trauma, hypervigilance, and sleep disturbance. As war is outside the realm of normal human experience, battle experiences nearly always fulfill the first criterion for the definition of PTSD (exposure to a severe, traumatic event). The clinical manifestations and diagnostic criteria for PTSD are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=see_link&amp;anchor=H10#H10\">",
"     \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of PTSD and other mental health disorders varies based on the particular war, the veteran population being studied (eg, gender, branch of military), and when PTSD assessment is being performed (soon after return compared to years later). As an example, whereas 6.2 percent of Army soldiers returning from Afghanistan met screening criteria for PTSD, 12.9 percent met criteria after deployment to Iraq [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/19\">",
"     19",
"    </a>",
"    ]. PTSD and other psychological sequelae are being identified at higher rates than has historically been the case, and they frequently are not fully manifest until months or years after return [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/17,22,23\">",
"     17,22,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=see_link&amp;anchor=H6#H6\">",
"     \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\", section on 'Combat'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The PTSD checklist (PCL) may be helpful in screening patients for PTSD and monitoring the progress of treatment over time [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/24\">",
"     24",
"    </a>",
"    ]. Versions of this tool have been developed for civilian and military populations (",
"    <a class=\"graphic graphic_form graphicRef51518 \" href=\"UTD.htm?16/39/17013\">",
"     form 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_form graphicRef65285 \" href=\"UTD.htm?13/7/13429\">",
"     form 1",
"    </a>",
"    ). A score of 50 out of a maximum score of 85 is associated with a diagnosis of PTSD. The PCL-M (military version of the PCL) is self-administered by patients and has been validated in military populations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The four-item PC-PTSD is a brief screening tool which has also been studied in a military population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=see_link&amp;anchor=H14#H14\">",
"     \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\", section on 'Instruments for screening and monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharmacotherapy (eg, selective serotonin reuptake inhibitors, SSRIs) and trauma-focused cognitive behavioral therapy are effective for patients with PTSD. However, PTSD in combat veterans may be more resistant to both pharmacologic and non-pharmacologic approaches. Thus, combination therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a longer duration of therapy may be warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33239?source=see_link\">",
"     \"Pharmacotherapy for posttraumatic stress disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5032?source=see_link\">",
"     \"Psychotherapy for posttraumatic stress disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An expert panel convened by the Institute of Medicine concluded that exposure therapy is the most effective behavioral treatment for PTSD [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/28\">",
"     28",
"    </a>",
"    ]. Some studies found that prolonged imaginal exposure (asking the patient to close their eyes and vividly describe the trauma in first person, present tense) is as effective in combat veterans as in other populations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Virtual reality exposure therapy provides an alternative exposure method to facilitate recall which is efficacious in military service members with combat-related PTSD [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/31\">",
"     31",
"    </a>",
"    ]. Both forms of exposure therapy utilize cognitive behavioral therapy as a foundation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H341622527\">",
"    <span class=\"h2\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to PTSD, depression and anxiety disorders are also significantly associated with war [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/19\">",
"     19",
"    </a>",
"    ]. Whereas 6.9 percent of Army soldiers returning from Afghanistan met screening criteria for depression, 7.9 percent met criteria after deployment to Iraq. Depression is a major public health problem worldwide and a leading predictor of functional disability and mortality, particularly in returning veterans with disability [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/33\">",
"     33",
"    </a>",
"    ]. The clinical manifestations of depression are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The nine-item Patient Health Questionnaire (PHQ-9) has been the most studied and widely-used questionnaire for detection of depression (",
"    <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"     table 2",
"    </a>",
"    ). It is brief, easy to use, and covers all of the DSM-IV-TR diagnostic criteria for unipolar major depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4745?source=see_link&amp;anchor=H184319686#H184319686\">",
"     \"Using scales to monitor symptoms and treatment of depression (measurement based care)\", section on 'Commonly used self-report depression scales'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Major depression is a treatable illness that responds to a variety of therapeutic interventions, including psychotherapy and pharmacotherapy. Other modalities (eg, electroconvulsive therapy, deep brain stimulation) may be needed in patients who do not respond to initial therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=see_link\">",
"     \"Treatment of resistant depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H341622519\">",
"    <span class=\"h2\">",
"     Generalized anxiety disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized anxiety disorder (GAD) is characterized by excessive worry that is difficult to control and causes significant distress and impairment. Anxiety disorders are associated with an increased risk for multiple medical conditions, including myocardial infarction among veterans [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/34\">",
"     34",
"    </a>",
"    ]. Anxiety is often accompanied by other mental health problems among veterans, including depression, panic disorder, and substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/35\">",
"     35",
"    </a>",
"    ]. A diagnostic algorithm to help distinguish GAD from major depression and other disorders can be found in the figure (",
"    <a class=\"graphic graphic_algorithm graphicRef63149 \" href=\"UTD.htm?31/27/32191\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A seven-item anxiety questionnaire (GAD-7) has been developed and validated in a primary care setting to help detect generalized anxiety disorder (",
"    <a class=\"graphic graphic_table graphicRef77755 \" href=\"UTD.htm?31/30/32236\">",
"     table 3",
"    </a>",
"    ). Additionally, the first two items of the GAD-7 tool (referred to as the GAD-2) may be equally sensitive to the GAD-7 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/36\">",
"     36",
"    </a>",
"    ]. The PHQ-4, which combines the GAD-2 with the PHQ-2 (the two questions from the PHQ-9 that address mood and anhedonia) provides reasonable sensitivity and specificity for the full range of anxiety and mood disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H341622527\">",
"     'Depression'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both pharmacotherapy and cognitive behavioral therapy are efficacious as first-line treatment for generalized anxiety disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=see_link\">",
"     \"Pharmacotherapy for generalized anxiety disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770042\">",
"    <span class=\"h2\">",
"     Suicide risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of stress from the modern combat environment, particularly in the setting of life-threatening situations, as well as being away from home and family for long periods, predisposes soldiers to a higher risk of suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. The wars in Afghanistan and Iraq have been associated with frequent suicidal ideation and the highest suicide rates in US military personnel since rates began being tracked in 1980 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/40\">",
"     40",
"    </a>",
"    ]. For the US Army, there were 9.8 suicides per 100,000 in 2002, rising to 20.2 per 100,000 by 2008. By comparison, the civilian rate was 19.8 in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/38\">",
"     38",
"    </a>",
"    ]. The military has historically had lower rates than the general population, presumably because service members are screened for physical and mental health concerns before enlistment (also known as the &lsquo;healthy soldier effect&rsquo;) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/41\">",
"     41",
"    </a>",
"    ]. One study estimated that veterans are 2.3 times more likely to die of suicide compared to the rest of the population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Department of Defense, the Veterans Administration, and other organizations in the US have established several programs to prevent suicide in military service members [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/42\">",
"     42",
"    </a>",
"    ]. Multidisciplinary suicide prevention programs designed for injured returning veterans may reduce the number of suicides related to combat-related injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/20\">",
"     20",
"    </a>",
"    ]. Possible interventions include removing stigma of seeking help, enhancing understanding of mental health, recognizing warning signs, and social outreach, including reintegration of the veteran into society. Although these programs appear to be helpful in suicide prevention, it is not clear which prevention initiatives are most effective for veterans given the absence of comparative data [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to a veteran suspected of suicide risk is similar to the civilian approach. Patients should be asked about suicidal ideation and intent, and, if present, the lethality of the plan should be evaluated. Patients at imminent risk for suicide require immediate psychiatric services and must be monitored continuously until they are in a safe situation. After immediate safety has been ensured, underlying factors of psychiatric disorders, precipitating events, and ongoing life circumstances should be addressed with medications, counseling, and involvement of friends, family, and",
"    <span class=\"nowrap\">",
"     religious/community",
"    </span>",
"    groups as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=see_link\">",
"     \"Suicidal ideation and behavior in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796205\">",
"    <span class=\"h2\">",
"     Psychological complications of amputation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amputation increases the risk of psychological sequelae, above and beyond the risk simply associated with having been in a warzone [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/44\">",
"     44",
"    </a>",
"    ]. Loss of a limb can profoundly influence one&rsquo;s self-image. One study found high rates of depression and anxiety up to two years post-amputation, which appear to decline thereafter to rates of the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concerns about independence and physical prowess may be more important than bodily image in military service members and veterans. Technological advances in prosthetics and rehabilitation enable a greater approximation to prior functional status and psychological recovery. There is limited literature addressing treatment of psychological factors associated with limb amputation. Based on evidence that more adaptive coping styles are associated with improved psychosocial adjustment and well-being, cognitive behavioral therapy should be incorporated into the management plan for veteran amputees [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/18,46\">",
"     18,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3796212\">",
"    <span class=\"h2\">",
"     Psychological complications of traumatic brain injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between traumatic brain injury (TBI) and psychological sequelae is complex. At least one-quarter to one-half of those with a history of TBI have major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. The overwhelming majority of those who experience a TBI during deployment to Afghanistan or Iraq are categorized as mild TBI, and there is a significant association between mild TBI and psychiatric symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. One study found that more than 40 percent of those who had loss of consciousness met criteria for PTSD [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/50\">",
"     50",
"    </a>",
"    ]. In this study, high rates of physical symptoms reported by soldiers could be attributed to PTSD and depression; when these conditions were accounted for in the analyses, there was no direct relationship between mild TBI and physical health problems (with the exception of headaches). Another study found that more than half of those in the VA system with a TBI diagnosis also had PTSD [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/52\">",
"     52",
"    </a>",
"    ]. In a mail survey of 2235 US military personnel returning from Afghanistan and Iraq, the PTSD score was more closely associated with residual TBI symptoms than any other factor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2154256\">",
"    <span class=\"h1\">",
"     CHRONIC PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common reason for recently deployed veterans to seek medical care is chronic pain associated with musculoskeletal injuries or traumatic brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/51\">",
"     51",
"    </a>",
"    ]. Multidisciplinary care, involving physical therapy and mental health treatments such as cognitive behavioral therapy or biofeedback techniques, has been successful for the treatment of chronic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/53\">",
"     53",
"    </a>",
"    ]. Complementary medicine approaches such as acupuncture, yoga, relaxation training, and meditation may be used as adjunctive therapy. PTSD and other psychiatric conditions are frequently comorbid and are associated with significantly greater rates of high-risk opiate use and consequent adverse events. Opiates should be prescribed with caution, if at all [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42778?source=see_link\">",
"     \"Overview of the treatment of chronic pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=see_link&amp;anchor=H15#H15\">",
"     \"Subacute and chronic low back pain: Pharmacologic and noninterventional treatment\", section on 'Activity and physical treatments'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H283153424\">",
"    <span class=\"h1\">",
"     SUBSTANCE ABUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stress of war leads to adverse health behaviors for some military service members. One anonymous self-report survey of more than 28,000 US military personnel found that cigarette smoking was the most common adverse behavior (31.7 percent), followed by heavy alcohol use (21.0 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/55\">",
"     55",
"    </a>",
"    ]. Illicit drug use excluding prescription drug misuse was reported in 5.2 percent. The rate has declined sharply since 1980, associated with random drug testing and strict intolerance of drug use within military ranks. Although differences in methodology make direct comparisons difficult, rates within the military appear to at least be no higher than in the general population. However, prescriptions for psychotropic medications, and abuse of prescription medications, have increased markedly in the general population in recent years, and this trend seems to be even more pronounced in the military in association with drawn out conflicts in Iraq and Afghanistan [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. In another study using data from the VA healthcare system for veterans of Iraq and Afghanistan seen for an initial visit between 2001 and 2009, alcohol use disorder was diagnosed in 10 percent, drug use disorder in 5 percent, and both diagnoses in 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/58\">",
"     58",
"    </a>",
"    ]. Over 55 percent of veterans diagnosed with alcohol or drug abuse were also diagnosed with either PTSD or depression and were 3.0 to 4.5 times more likely to have PTSD or depression than veterans without substance abuse. Additionally, veterans with mental health diagnoses (and PTSD in particular) were more likely to have chronic pain requiring opioid treatment and were more likely to abuse prescription opioids with adverse health consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/54\">",
"     54",
"    </a>",
"    ]. It is important to recognize that an element of selection bias occurs, with healthier individuals who are less likely to engage in illicit drug use tending to remain in active military service at higher rates. Conversely, for those who leave the military, only about one-quarter receive care in the VA system, and they tend to be disproportionately impoverished with more complex health problems [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The frequency and intensity of tobacco use increases in military populations after deployment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/55\">",
"     55",
"    </a>",
"    ]. Smoking rates are particularly high in those with combat-related PTSD. Tobacco cessation efforts that are integrated with PTSD treatment have been found to be more effective than referral to standard smoking cessation programs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. In advocating for smoking cessation in the veteran population, any concomitant psychological sequelae should also be addressed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although rates of alcohol or substance dependence are comparable in military service members and their civilian counterparts, alcohol misuse (including drinking and driving, and being late for or missing work due to a hangover) seems to be more common after deployment, with 27 percent of veterans reporting this [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/63\">",
"     63",
"    </a>",
"    ]. Alcohol misuse is associated with combat exposures involving threat of death or injury, as well as current functional impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/64\">",
"     64",
"    </a>",
"    ]. Thus, combat veterans returning from deployment should be screened for alcohol misuse. Their use of prescription and non-prescription medications should be carefully reviewed, with attention to unauthorized or illicit drug use as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/24/25993?source=see_link\">",
"     \"Screening for unhealthy use of alcohol and other drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770835\">",
"    <span class=\"h1\">",
"     INFECTIOUS DISEASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Veterans are at risk for a wide range of infectious diseases, depending on the endemic infectious agents of the particular combat area. Risk can be decreased by protective measures taken by veterans (eg, clothing, insect repellant, prophylactic medications).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770842\">",
"    <span class=\"h2\">",
"     Malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasmodium vivax and Plasmodium falciparum are endemic in Afghanistan [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/65\">",
"     65",
"    </a>",
"    ]. All soldiers from the US deployed to Afghanistan are treated with chemoprophylaxis (mostly with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/66\">",
"     66",
"    </a>",
"    ] and receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    terminal prophylaxis upon return. P. falciparum is generally apparent within two weeks of exposure and thus does not have a late presentation following return from deployment. However, P. vivax can present with late-onset or relapsing disease many months after initial infection, and should be considered in the differential diagnosis of any veteran with fevers returning from Afghanistan. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=see_link\">",
"     \"Clinical manifestations of malaria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4394?source=see_link\">",
"     \"Overview of non-falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770849\">",
"    <span class=\"h2\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) is endemic in Afghanistan and Iraq. The US military screens soldiers at high risk of exposure for TB prior to deployment using the purified protein derivative of tuberculin (PPD) and within 10 weeks of return from deployment. Deployment-associated conversion rates are approximately 2.5 percent in soldiers returning from Afghanistan and Iraq [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/67\">",
"     67",
"    </a>",
"    ]. Soldiers identified with latent or active TB infection should receive appropriate treatment. However, it is conceivable that returning veterans, especially in the Reserve or National Guard, could bypass screening processes in place by the military. Providers should inquire as to the PPD status of returning veterans, and should screen for TB if status is unknown. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H73400661\">",
"    <span class=\"h2\">",
"     Wound infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wounds sustained in battle are frequently infected [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/68\">",
"     68",
"    </a>",
"    ]. Lower extremity wounds are likely to be due to improvised explosive devices (IEDs) or land mines, and are at high risk of infection. Antibiotic therapy should be tailored to cultures due to the propensity of Acinetobacter and other gram negative organisms (eg, Enterobacter, Pseudomonas) to cause wound infections, as well as antibiotic resistant organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In addition, invasive fungal infections, including mucormycosis, have been reported in United States military personnel who sustained blast injuries during combat in Afghanistan [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37761?source=see_link\">",
"     \"Clinical microbiology review: Wound, skin, and soft tissue infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19078?source=see_link\">",
"     \"Clinical assessment of wounds\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link\">",
"     \"Mucormycosis (zygomycosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=see_link&amp;anchor=H244297312#H244297312\">",
"     \"Mucormycosis (zygomycosis)\", section on 'Combat-associated'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H73400668\">",
"    <span class=\"h3\">",
"     Antibiotic resistant bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the beginning of US operations in Afghanistan and Iraq, there has been a notable increase in the number of wounded veterans with colonization or infection with antibiotic resistant organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/72\">",
"     72",
"    </a>",
"    ]. Common organisms include methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)&ndash;producing gram negative organisms (particularly Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Acinetobacter baumannii) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/69,73,74\">",
"     69,73,74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30553?source=see_link\">",
"     \"Extended-spectrum beta-lactamases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Wounded soldiers arriving to military medical treatment facilities are screened for colonization upon arrival. The colonization status of returning veterans may not be known to providers outside of military treatment facilities. Providers caring for returning veterans should be aware of possible",
"    <span class=\"nowrap\">",
"     colonization/infection",
"    </span>",
"    with resistant organisms, and should take this into account when considering antibiotic selection and implementing infection control practices. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770856\">",
"    <span class=\"h2\">",
"     Cutaneous leishmaniasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous leishmaniasis is a recognized parasitic infection in soldiers returning from Afghanistan and Iraq and presents as chronic, painless ulcerations on areas of skin exposure, most commonly the arms and legs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/75\">",
"     75",
"    </a>",
"    ]. While lesions from cutaneous leishmaniasis can present within 7 to 10 days of exposure, patients often do not seek medical care until they become chronic (assuming ulcers will heal spontaneously). Thus, cutaneous leishmaniasis typically presents in a window from 6 to 12 months after exposure, and should be considered in the differential of painless ulcerations in veterans returning from Afghanistan and Iraq. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/18/33063?source=see_link\">",
"     \"Epidemiology, clinical manifestations and diagnosis of cutaneous leishmaniasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/43/20152?source=see_link\">",
"     \"Skin lesions in the returning traveler\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770863\">",
"    <span class=\"h2\">",
"     Visceral leishmaniasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are case reports of visceral leishmaniasis occurring in soldiers returning from Afghanistan and Iraq [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/76\">",
"     76",
"    </a>",
"    ]. Clinical features include chronic fever, weight loss, fatigue, abdominal discomfort that may localize to the left upper quadrant, and hepatosplenomegaly. Laboratory abnormalities include anemia, leukopenia, and elevated liver-associated enzymes. Highly-sensitive and specific serology-based ELISA testing utilizing recombinant kinesin antigen (rK39) is commercially available to aid in the diagnosis. Visceral leishmaniasis should be considered in the differential diagnosis of veterans with chronic fever and weight loss without any obvious cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21161?source=see_link\">",
"     \"Clinical manifestations and diagnosis of visceral leishmaniasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770870\">",
"    <span class=\"h2\">",
"     Q fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Q fever is a zoonotic infection due to Coxiella burnetii, with both acute and chronic manifestations. The incubation period is relatively short, so the acute presentation of Q fever as a self-limited flu-like illness, pneumonia, or hepatitis is typically seen while soldiers are still deployed or immediately following return [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/77\">",
"     77",
"    </a>",
"    ]. However, it can also present as a chronic infection, most commonly as endocarditis which is the most serious and potentially fatal form. Q fever should be considered in all cases of blood culture-negative endocarditis in returning veterans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12502?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Q fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=see_link\">",
"     \"Q fever endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770906\">",
"    <span class=\"h2\">",
"     Brucellosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brucellosis is a zoonotic infection endemic to Afghanistan and Iraq that can vary widely in clinical presentation, ranging from asymptomatic, to insidious onset of nonspecific findings, to acute illness and death [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/67\">",
"     67",
"    </a>",
"    ]. The incubation period is usually one to four weeks. A presumptive diagnosis of brucellosis can be made by demonstrating high or rising titers of specific antibodies in the serum in the presence of clinical manifestations.",
"    <sup>",
"    </sup>",
"    This is the most commonly used diagnostic method in clinical practice. The diagnosis of brucellosis is made with certainty when brucellae are isolated from blood, bone marrow, or other body fluids or tissues. Brucellosis should be considered in the differential diagnosis of a fever of unknown origin in veterans who have recently returned from deployment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of brucellosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770913\">",
"    <span class=\"h2\">",
"     Anthrax and smallpox vaccinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite controversy regarding the utility of anthrax and smallpox vaccinations, both vaccines have been administrated broadly in several military populations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. While there can be serious short-term side effects following vaccination, no long-term complications have been described following small pox or anthrax vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/7/40057?source=see_link\">",
"     \"Vaccinia virus as the smallpox vaccine\"",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/58/18342?source=see_link\">",
"     \"Anthrax vaccine adsorbed: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46284381\">",
"    <span class=\"h2\">",
"     Transfusion-related infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhage is the leading preventable cause of mortality in combat casualties [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/82\">",
"     82",
"    </a>",
"    ], and death from hemorrhage usually occurs within 6 to 24 hours of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/83,84\">",
"     83,84",
"    </a>",
"    ]. Blood products to replace losses must be available at military treatment facilities, which are often located in austere conditions. Stored red blood cells, frozen plasma, and cryoprecipitate products used in battle are fully compliant with US Food and Drug Administration (FDA) regulations. Platelets have a short shelf-life and cannot be collected, tested, and transported in time for use for most casualties.",
"   </p>",
"   <p>",
"    In some cases, transfusion requirements of one or more casualties exceed the supplies of stored blood components and blood components that have been prescreened for transfusion-transmitted infectious pathogens in accordance with FDA regulations are unavailable [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/85\">",
"     85",
"    </a>",
"    ]. To address the need for life-saving blood products in such conditions, non&ndash;FDA-compliant, voluntarily donated, and freshly collected blood products (whole blood and apheresis platelets) may be needed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. Donors of emergency blood products are usually US service members located near the receiving medical unit. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=see_link\">",
"     \"Procedures used for blood donor screening: Protection of potential blood donors and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Countermeasures to reduce the risk of transfusion-transmitted infections have been implemented to include human immunodeficiency virus (HIV) screening of personnel prior to deployment, compulsory hepatitis B virus (HBV) vaccination, donor questionnaire forms to screen for high-risk exposure history, and rapid diagnostic testing for HIV, HBV, and hepatitis C virus (HCV). As apheresis platelets can be donated relatively frequently, pedigree donors who have previously been screened are used preferentially. However, there remains residual risk for transfusion-transmitted infections [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/88,89\">",
"     88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    US Department of Defense policy requires screening recipients of non-FDA compliant blood products (specifically fresh whole blood or apheresis platelets collected on site) for HIV, HBV, HCV, human T-lymphtropic virus (HTLV), and rapid plasma reagin (RPR) at 3, 6, and 12 months following the transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/90\">",
"     90",
"    </a>",
"    ]. Soldiers are given notification when they have received an emergency blood transfusion and are provided with a letter containing an explanation of required screening tests. Soldiers are advised to keep the letter and provide a copy to their clinicians who are providing follow-up care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770934\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL HAZARDS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46284479\">",
"    <span class=\"h2\">",
"     Noise exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noise-related hearing loss and tinnitus are two of the most prevalent service-connected disabilities among US veterans [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. US soldiers have mandatory audiology screening prior to deployment to provide a baseline hearing assessment, and audiology testing is performed if returning veterans report hearing loss or tinnitus. It is reasonable to assess for hearing loss and tinnitus in returning veterans and refer for audiology evaluation if either is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/32/39429?source=see_link\">",
"     \"Evaluation of hearing loss in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26727?source=see_link\">",
"     \"Etiology and diagnosis of tinnitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The US National Center for Rehabilitative Auditory Research has developed a computer-based, multimedia hearing loss prevention program for military personnel [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/93\">",
"     93",
"    </a>",
"    ]. Its focus is to encourage veterans to employ hearing protective strategies on a regular basis. Its availability is being expanded to veterans via the Internet and at medical centers throughout the US [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4770942\">",
"    <span class=\"h2\">",
"     Toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although concerns have been raised about environmental toxins from previous wars leading to adverse health effects, these exposures have not been widely reported with the conflicts in Afghanistan or Iraq. These hazards include Agent Orange (dioxin) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/95\">",
"     95",
"    </a>",
"    ], sulfur mustards (mustard gas) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/96\">",
"     96",
"    </a>",
"    ], other toxic nerve agents (eg, sarin, cyclosarin) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/97,98\">",
"     97,98",
"    </a>",
"    ], and heavy metals [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/99\">",
"     99",
"    </a>",
"    ]. The herbicide Agent Orange has received considerable attention due to widespread use in the Vietnam War by the US for military purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/100\">",
"     100",
"    </a>",
"    ]. The long-term health effects of Agent Orange are controversial, but an association with certain cancers, including prostate cancer, soft tissue sarcomas, and non-Hodgkin&rsquo;s lymphoma, has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. The Institute of Medicine in the US biennially updates a comprehensive report on the",
"    <a class=\"external\" href=\"file://www.iom.edu/Reports/2011/Veterans-and-Agent-Orange-Update-2010.aspx\">",
"     health consequences of Agent Orange",
"    </a>",
"    exposure, based on ongoing evaluation.",
"   </p>",
"   <p>",
"    Numerous environmental exposures, including oil well fires, toxic nerve agents, and insect repellents have been postulated to be associated with persistent symptoms in Persian Gulf War veterans called &lsquo;Gulf War Syndrome,&rsquo; but no single etiological factor has been found to account for these medically unexplained symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/103-106\">",
"     103-106",
"    </a>",
"    ]. Common symptoms of Gulf War Syndrome include headache, fatigue, joint",
"    <span class=\"nowrap\">",
"     pain/stiffness,",
"    </span>",
"    cognitive difficulties, and insomnia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the safety of independent use of insect repellents diethyl-meta-toluamide (DEET) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    is well-documented [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/108,109\">",
"     108,109",
"    </a>",
"    ], concerns were raised during the Persian Gulf War in the early 1990&rsquo;s after animal studies found that concomitant use of these insect repellants with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/55/27509?source=see_link\">",
"     pyridostigmine",
"    </a>",
"    bromide (used as prophylaxis against nerve agent exposure) was associated with chronic neurotoxic syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/110\">",
"     110",
"    </a>",
"    ]. A subsequent randomized trial in humans compared appropriate doses of all three treatments in combination compared to placebo and found no adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/111\">",
"     111",
"    </a>",
"    ]. However, fears spawned by the earlier animal studies have occasionally led service members to forgo the use of insect repellents, resulting in higher rates of malaria and other insect-borne diseases compared to those who regularly use the combination of permethrin treatment of clothing and DEET application to the skin. Veterans who may be deployed should be counseled on the benefits and safety of insect repellant use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4769426\">",
"    <span class=\"h1\">",
"     DISABILITY AND FUNCTIONAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2010, the US Census Bureau reported that there were a total of 22.0 million living veterans in the US, of which 3.2 million veterans received service connected disability compensation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Functional capacity assessments are commonly performed by military treating facilities (including the US Veterans Administration Hospitals). If the veteran has symptoms or signs of functional or mobility problems, then physical, occupational,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    speech therapy evaluations should be conducted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22873?source=see_link\">",
"     \"Disability assessment and determination in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Military members in the US who have physical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mental health conditions that render them unfit to perform their required duties are reviewed by a Medical Evaluation Board. The board consists of active duty physicians (not involved in the care of the military member) who review the clinical case file and decide whether the individual should be returned to duty, or should be separated, using published medical standards for continued military service (Army Regulation 40-501 Standards of Medical Fitness) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/113\">",
"     113",
"    </a>",
"    ]. If the member's medical condition falls below medical retention standards, the case is forwarded to a Physical Evaluation Board (PEB). The PEB is a formal fitness-for-duty and disability determination that may recommend return of the member to duty (with or without assignment limitations which are documented and outlined in a &ldquo;physical profile&rdquo;), transfer of the member from active duty, or medical retirement of the member temporarily or permanently. The standard used by the PEB for determining fitness is whether the medical condition precludes the member from reasonably performing the duties of his or her office, rank, or position. Military members who are separated or medically retired are given a disability rating by the PEB based off of the Department of Veterans Affairs Schedule for Rating Disabilities [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most US military personnel are active duty service members, and are therefore eligible for care within the Department of Defense military treatment facilities upon their return from deployment. However, more than one-quarter of those who have been deployed are National Guard or Reserve service members who are activated specifically for deployment. Health problems or injuries that occur during service, or are deemed to be service-connected when identified after deployment, can result in service members being eligible for care in the Department of Defense or Veterans Administration",
"    <span class=\"nowrap\">",
"     hospitals/clinics",
"    </span>",
"    for the remainder of their lives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46283896\">",
"    <span class=\"h1\">",
"     SOCIAL STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Being confronted with &ldquo;kill or be killed&rdquo; scenarios, and being on guard day and night for a prolonged period of time, represents an enormous life stressor. This stress can result in a wide variety of physical and psychological symptoms that may become apparent at home and persist for months to years, if not indefinitely. Deployment has a significant impact not only on military service members, but also on their families [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/115,116\">",
"     115,116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stressors on families include the separation from a parent who would otherwise be providing care and attention to children, the single parent left behind having to manage all household duties, and fears that the deployed member might be injured or die. Up to half of military families relocate during deployment to be closer to extended families, but this often comes at the price of disruption in school and friendships for children, interruption in employment for the remaining spouse, and loss of support that might be provided by the military community or the previous home community [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/117\">",
"     117",
"    </a>",
"    ]. Frequent uncertainty regarding when the service member will deploy, and when they will return home, is a significant source of anxiety. Rates of marital conflict, domestic violence, and divorce are higher in families where a member has been deployed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/5/28762/abstract/118,119\">",
"     118,119",
"    </a>",
"    ]. In caring for a returning veteran, the clinician should evaluate the situation at home, paying attention to the veteran&rsquo;s marital, parental, and community relationships.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One important resource for helping veterans and their families cope with deployment stress is FOCUS (Families Overcoming Under Stress), which provides both on-site support at a number of military bases, as well as on-line information and tools",
"    <span class=\"nowrap\">",
"     (www.focusproject.org/home).",
"    </span>",
"    FOCUS provides state-of-the-art resiliency training for both children and adult members of military families at various stages, including deployment, return from duty, and redeployment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H616481677\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although the overall medical care of the returning veteran may be similar to that of the general population, there are certain issues (eg, combat injuries, PTSD, readjustment to society following deployment) that pertain specifically to the veteran. Physical injuries from combat (eg, amputations, traumatic brain injury) can lead to significant functional limitations as well psychological sequelae. (See",
"      <a class=\"local\" href=\"#H3796170\">",
"       'Physical injury due to combat'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3796198\">",
"       'Psychological sequelae'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PTSD and other psychological sequelae in veterans are being identified at higher rates than in the past. Psychological symptoms frequently are not fully manifest until months or years after return from deployment. The military PTSD checklist (PCL-M) (",
"      <a class=\"graphic graphic_form graphicRef65285 \" href=\"UTD.htm?13/7/13429\">",
"       form 1",
"      </a>",
"      ), Patient Health Questionnaire (PHQ-9) for depression (",
"      <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"       table 2",
"      </a>",
"      ), and the generalized anxiety disorder questionnaire (GAD-7) (",
"      <a class=\"graphic graphic_table graphicRef77755 \" href=\"UTD.htm?31/30/32236\">",
"       table 3",
"      </a>",
"      ) are among the most frequently-used and effective screening questionnaires. As screening a single time shortly after return from deployment will miss most cases of mental health problems, repeated screening is necessary, particularly between 3 and 12 months after return from duty. (See",
"      <a class=\"local\" href=\"#H3796198\">",
"       'Psychological sequelae'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=see_link\">",
"       \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"       \"Clinical manifestations and diagnosis of depression\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"       \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The approach to a veteran suspected of suicide risk is similar to the approach for civilians. Veterans suspected to be at risk for suicide should be asked about suicidal ideation and intent, and, if present, the lethality of the plan should be evaluated. Veterans at imminent risk for suicide require immediate psychiatric services and must be monitored continuously until they are in a safe situation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=see_link\">",
"       \"Suicidal ideation and behavior in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Veterans are at risk for a wide range of infectious diseases, depending on the endemic infectious agents of the particular combat area. (See",
"      <a class=\"local\" href=\"#H4770835\">",
"       'Infectious diseases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noise-related hearing loss and tinnitus are two of the most prevalent service-connected disabilities among US veterans. Other environmental exposures such as toxic nerve agents have been documented in previous wars, but have not been implicated in the more recent wars in Afghanistan and Iraq. (See",
"      <a class=\"local\" href=\"#H4770934\">",
"       'Environmental hazards'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the veteran has symptoms or signs of functional or mobility problems, then physical and occupational therapy evaluations should be conducted. (See",
"      <a class=\"local\" href=\"#H4769426\">",
"       'Disability and functional assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Finally, the clinician should evaluate the situation at home, paying attention to the veteran&rsquo;s familial and community relationships, as veterans are prone to have difficulties in the transition back to civilian life. (See",
"      <a class=\"local\" href=\"#H46283896\">",
"       'Social stress'",
"      </a>",
"      above.) Efforts should be made to address any barriers to care and to enlist the help of interdisciplinary teams (eg, psychiatry, physical therapy, social work) in this goal.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/1\">",
"      Clouse WD, Rasmussen TE, Peck MA, et al. In-theater management of vascular injury: 2 years of the Balad Vascular Registry. J Am Coll Surg 2007; 204:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/2\">",
"      Landrum ML, Murray CK. Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program. J Trauma 2008; 64:S123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/3\">",
"      Wojcik BE, Humphrey RJ, Czejdo B, Hassell LH. U.S. Army disease and nonbattle injury model, refined in Afghanistan and Iraq. Mil Med 2008; 173:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/4\">",
"      Roy MJ, Koslowe PA, Kroenke K, Magruder C. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the Comprehensive Clinical Evaluation Program. Psychosom Med 1998; 60:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/5\">",
"      Kragh JF Jr, Walters TJ, Baer DG, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma 2008; 64:S38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/6\">",
"      Ritenour AE, Dorlac WC, Fang R, et al. Complications after fasciotomy revision and delayed compartment release in combat patients. J Trauma 2008; 64:S153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/7\">",
"      Minei JP, Schmicker RH, Kerby JD, et al. Severe traumatic injury: regional variation in incidence and outcome. Ann Surg 2010; 252:149.",
"     </a>",
"    </li>",
"    <li>",
"     War Surgery in Afghanistan and Iraq: A Series of Cases, 2003&ndash;2007, Nessen SC, Lounsbury DE, Hetz SP (Eds), Department of the Army, Washington, DC 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/9\">",
"      Stansbury LG, Lalliss SJ, Branstetter JG, et al. Amputations in U.S. military personnel in the current conflicts in Afghanistan and Iraq. J Orthop Trauma 2008; 22:43.",
"     </a>",
"    </li>",
"    <li>",
"     www.bordeninstitute.army.mil/published_volumes/amputee/amputee.html (Accessed on February 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/11\">",
"      Reiber GE, McFarland LV, Hubbard S, et al. Servicemembers and veterans with major traumatic limb loss from Vietnam war and OIF/OEF conflicts: survey methods, participants, and summary findings. J Rehabil Res Dev 2010; 47:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/12\">",
"      Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 2008; 358:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/13\">",
"      Mac Donald CL, Johnson AM, Cooper D, et al. Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med 2011; 364:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/14\">",
"      Giacino JT, Whyte J, Bagiella E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012; 366:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/15\">",
"      Weaver FM, Burns SP, Evans CT, et al. Provider perspectives on soldiers with new spinal cord injuries returning from Iraq and Afghanistan. Arch Phys Med Rehabil 2009; 90:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/16\">",
"      Seal KH, Metzler TJ, Gima KS, et al. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health 2009; 99:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/17\">",
"      Grieger TA, Cozza SJ, Ursano RJ, et al. Posttraumatic stress disorder and depression in battle-injured soldiers. Am J Psychiatry 2006; 163:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/18\">",
"      Thomas JL, Wilk JE, Riviere LA, et al. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch Gen Psychiatry 2010; 67:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/19\">",
"      Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/20\">",
"      Knox KL, Litts DA, Talcott GW, et al. Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: cohort study. BMJ 2003; 327:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/21\">",
"      Cohen BE, Marmar C, Ren L, et al. Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA 2009; 302:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/22\">",
"      Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA 2006; 295:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/23\">",
"      Andrews B, Brewin CR, Philpott R, Stewart L. Delayed-onset posttraumatic stress disorder: a systematic review of the evidence. Am J Psychiatry 2007; 164:1319.",
"     </a>",
"    </li>",
"    <li>",
"     Weathers FW, Juska JA, Keane TM. The PTSD checklist - civilian version. Boston National Center for PTSD. Boston Veterans Affairs Medical Center 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/25\">",
"      Keen SM, Kutter CJ, Niles BL, Krinsley KE. Psychometric properties of PTSD Checklist in sample of male veterans. J Rehabil Res Dev 2008; 45:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/26\">",
"      Terhakopian A, Sinaii N, Engel CC, et al. Estimating population prevalence of posttraumatic stress disorder: an example using the PTSD checklist. J Trauma Stress 2008; 21:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/27\">",
"      Bliese PD, Wright KM, Adler AB, et al. Validating the primary care posttraumatic stress disorder screen and the posttraumatic stress disorder checklist with soldiers returning from combat. J Consult Clin Psychol 2008; 76:272.",
"     </a>",
"    </li>",
"    <li>",
"     Berg AO, Breslau N, Lezak MD, et al. Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence, National Academies Press, Washington, DC 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/29\">",
"      Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry 2011; 72:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/30\">",
"      Tuerk PW, Yoder M, Grubaugh A, et al. Prolonged exposure therapy for combat-related posttraumatic stress disorder: an examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq. J Anxiety Disord 2011; 25:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/31\">",
"      Reger GM, Holloway KM, Candy C, et al. Effectiveness of virtual reality exposure therapy for active duty soldiers in a military mental health clinic. J Trauma Stress 2011; 24:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/32\">",
"      Roy MJ, Francis J, Friedlander J, et al. Improvement in cerebral function with treatment of posttraumatic stress disorder. Ann N Y Acad Sci 2010; 1208:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/33\">",
"      Findley PA, Banerjea R, Sambamoorthi U. Excess mortality associated with mental illness and substance use disorders among veteran clinic users with spinal cord injury. Disabil Rehabil 2011; 33:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/34\">",
"      Scherrer JF, Chrusciel T, Zeringue A, et al. Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J 2010; 159:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/35\">",
"      Mittal D, Fortney JC, Pyne JM, Wetherell JL. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder. J Clin Psychiatry 2011; 72:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/36\">",
"      Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/37\">",
"      Kroenke K, Spitzer RL, Williams JB, L&ouml;we B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009; 50:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/38\">",
"      Haffner WH. Veteran suicide. Mil Med 2010; 175:i.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/39\">",
"      Kaplan MS, Huguet N, McFarland BH, Newsom JT. Suicide among male veterans: a prospective population-based study. J Epidemiol Community Health 2007; 61:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/40\">",
"      Pietrzak RH, Goldstein MB, Malley JC, et al. Risk and protective factors associated with suicidal ideation in veterans of Operations Enduring Freedom and Iraqi Freedom. J Affect Disord 2010; 123:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/41\">",
"      Bruce ML. Suicide risk and prevention in veteran populations. Ann N Y Acad Sci 2010; 1208:98.",
"     </a>",
"    </li>",
"    <li>",
"     www.health.mil/Themes/Suicide_Prevention.aspx.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/43\">",
"      Bossarte RM, Claassen CA, Knox KL. Evaluating evidence of risk for suicide among veterans. Mil Med 2010; 175:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/44\">",
"      Epstein RA, Heinemann AW, McFarland LV. Quality of life for veterans and servicemembers with major traumatic limb loss from Vietnam and OIF/OEF conflicts. J Rehabil Res Dev 2010; 47:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/45\">",
"      Horgan O, MacLachlan M. Psychosocial adjustment to lower-limb amputation: a review. Disabil Rehabil 2004; 26:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/46\">",
"      Desmond DM. Coping, affective distress, and psychosocial adjustment among people with traumatic upper limb amputations. J Psychosom Res 2007; 62:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/47\">",
"      Seel RT, Kreutzer JS, Rosenthal M, et al. Depression after traumatic brain injury: a National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation. Arch Phys Med Rehabil 2003; 84:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/48\">",
"      Jorge RE, Robinson RG, Moser D, et al. Major depression following traumatic brain injury. Arch Gen Psychiatry 2004; 61:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/49\">",
"      Kennedy RE, Livingston L, Riddick A, et al. Evaluation of the Neurobehavioral Functioning Inventory as a depression screening tool after traumatic brain injury. J Head Trauma Rehabil 2005; 20:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/50\">",
"      Schneiderman AI, Braver ER, Kang HK. Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am J Epidemiol 2008; 167:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/51\">",
"      Spelman JF, Hunt SC, Seal KH, Burgo-Black AL. Post deployment care for returning combat veterans. J Gen Intern Med 2012; 27:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/52\">",
"      Taylor BC, Hagel EM, Carlson KF, et al. Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users. Med Care 2012; 50:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/53\">",
"      Dobscha SK, Corson K, Perrin NA, et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA 2009; 301:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/54\">",
"      Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012; 307:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/55\">",
"      Bray RM, Pemberton MR, Lane ME, et al. Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010; 175:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/56\">",
"      Bray RM, Hourani LL. Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005. Addiction 2007; 102:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/57\">",
"      Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/58\">",
"      Seal KH, Cohen G, Waldrop A, et al. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug Alcohol Depend 2011; 116:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/59\">",
"      Wagner TH, Harris KM, Federman B, et al. Prevalence of substance use disorders among veterans and comparable nonveterans from the National Survey on Drug Use and Health. Psychological Services 2007; 4:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/60\">",
"      Hawkins EJ, Lapham GT, Kivlahan DR, Bradley KA. Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study. Drug Alcohol Depend 2010; 109:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/61\">",
"      McFall M, Saxon AJ, Thompson CE, et al. Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. Am J Psychiatry 2005; 162:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/62\">",
"      McFall M, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 2010; 304:2485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/63\">",
"      Santiago PN, Wilk JE, Milliken CS, et al. Screening for alcohol misuse and alcohol-related behaviors among combat veterans. Psychiatr Serv 2010; 61:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/64\">",
"      Wilk JE, Bliese PD, Kim PY, et al. Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. Drug Alcohol Depend 2010; 108:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/65\">",
"      Faulde MK, Hoffmann R, Fazilat KM, Hoerauf A. Malaria reemergence in northern Afghanistan. Emerg Infect Dis 2007; 13:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/66\">",
"      Croft AM, Darbyshire AH, Jackson CJ, van Thiel PP. Malaria prevention measures in coalition troops in Afghanistan. JAMA 2007; 297:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/67\">",
"      Aronson NE, Sanders JW, Moran KA. In harm's way: infections in deployed American military forces. Clin Infect Dis 2006; 43:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/68\">",
"      Murray CK, Roop SA, Hospenthal DR, et al. Bacteriology of war wounds at the time of injury. Mil Med 2006; 171:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/69\">",
"      Johnson EN, Burns TC, Hayda RA, et al. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis 2007; 45:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/70\">",
"      Dallo SF, Weitao T. Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010; 23:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/71\">",
"      Warkentien T, Rodriguez C, Lloyd B, et al. Invasive mold infections following combat-related injuries. Clin Infect Dis 2012; 55:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/72\">",
"      Weintrob AC, Roediger MP, Barber M, et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/73\">",
"      Keen EF 3rd, Murray CK, Robinson BJ, et al. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center. Infect Control Hosp Epidemiol 2010; 31:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/74\">",
"      Sensenig RA, Murray CK, Mende K, et al. Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties. Am J Infect Control 2012; 40:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/75\">",
"      Centers for Disease Control and Prevention (CDC). Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/76\">",
"      Myles O, Wortmann GW, Cummings JF, et al. Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004. Arch Intern Med 2007; 167:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/77\">",
"      Faix DJ, Harrison DJ, Riddle MS, et al. Outbreak of Q fever among US military in western Iraq, June-July 2005. Clin Infect Dis 2008; 46:e65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/78\">",
"      Weiss MM, Weiss PD, Weiss JB. Anthrax vaccine and public health policy. Am J Public Health 2007; 97:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/79\">",
"      LeardMann CA, Smith B, Smith TC, et al. Smallpox vaccination: comparison of self-reported and electronic vaccine records in the millennium cohort study. Hum Vaccin 2007; 3:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/80\">",
"      Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/81\">",
"      Niu MT, Ball R, Woo EJ, et al. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. Vaccine 2009; 27:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/82\">",
"      Kelly JF, Ritenour AE, McLaughlin DF, et al. Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma 2008; 64:S21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/83\">",
"      Peng R, Chang C, Gilmore D, Bongard F. Epidemiology of immediate and early trauma deaths at an urban Level I trauma center. Am Surg 1998; 64:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/84\">",
"      Demetriades D, Murray J, Charalambides K, et al. Trauma fatalities: time and location of hospital deaths. J Am Coll Surg 2004; 198:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/85\">",
"      Kauvar DS, Holcomb JB, Norris GC, Hess JR. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006; 61:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/86\">",
"      Repine TB, Perkins JG, Kauvar DS, Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma 2006; 60:S59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/87\">",
"      Perkins JG, Cap AP, Spinella PC, et al. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion 2011; 51:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/88\">",
"      Spinella PC, Perkins JG, Grathwohl KW, et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 2007; 35:2576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/89\">",
"      Hakre S, Peel SA, O'Connell RJ, et al. Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom. Transfusion 2011; 51:473.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.health.mil/libraries/HA_Policies_and_Guidelines/10-002.pdf (Accessed on March 21, 2012).",
"    </li>",
"    <li>",
"     Veterans Benefits Administration Annual Benefits Report Fiscal Year 2006. file://www.vba.va.gov/REPORTS/abr/index.asp (Accessed on February 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/92\">",
"      Centers for Disease Control and Prevention (CDC). Severe hearing impairment among military veterans--United States, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/93\">",
"      Folmer RL, Saunders GH, Dann SM, et al. Development of a Computer-Based, Multi-media Hearing Loss Prevention Education Program for Veterans and Military Personnel. Perspectives on Audiology 2010; 6:9.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ncrar.research.va.gov/aboutus/index.asp (Accessed on February 28, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/95\">",
"      Bullman TA, Kang HK. The effects of mustard gas, ionizing radiation, herbicides, trauma, and oil smoke on US military personnel: the results of veteran studies. Annu Rev Public Health 1994; 15:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/96\">",
"      Bullman T, Kang H. A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gGas. Ann Epidemiol 2000; 10:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/97\">",
"      Bullman TA, Mahan CM, Kang HK, Page WF. Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction. Am J Public Health 2005; 95:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/98\">",
"      Kang HK, Bullman T. Mortality follow-up of veterans who participated in military chemical and biological warfare agent testing between 1962 and 1972. J Toxicol Environ Health A 2009; 72:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/99\">",
"      Ryu H, Han JK, Jung JW, et al. Human health risk assessment of explosives and heavy metals at a military gunnery range. Environ Geochem Health 2007; 29:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/100\">",
"      Stellman JM, Stellman SD, Christian R, et al. The extent and patterns of usage of Agent Orange and other herbicides in Vietnam. Nature 2003; 422:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/101\">",
"      Schecter A, Needham L, Pavuk M, et al. Agent Orange exposure, Vietnam war veterans, and the risk of prostate cancer. Cancer 2009; 115:3369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/102\">",
"      Uzych L. Agent Orange, the Vietnam War, and lasting health effects. Environ Health Perspect 1991; 95:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/103\">",
"      Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War veterans. Latency of onset and lack of association with self-reported exposures. J Occup Environ Med 1998; 40:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/104\">",
"      Roy MJ, Kraus PL, Seegers CA, et al. Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. Mayo Clin Proc 2006; 81:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/105\">",
"      Schmidt CW. Soldiers and oil well smoke. Respiratory connection remains hazy. Environ Health Perspect 2002; 110:A690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/106\">",
"      Gronseth GS. Gulf war syndrome: a toxic exposure? A systematic review. Neurol Clin 2005; 23:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/107\">",
"      Ismail K. A review of the evidence for a \"Gulf War syndrome\". Occup Environ Med 2001; 58:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/108\">",
"      Robbins PJ, Cherniack MG. Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health 1986; 18:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/109\">",
"      Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/110\">",
"      Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 1997; 277:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/111\">",
"      Roy MJ, Kraus PL, Seegers CA, et al. Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. Mayo Clin Proc 2006; 81:1303.",
"     </a>",
"    </li>",
"    <li>",
"     Tables 552 and 524. In: Statistical Abstract of the United States: 2012. Available at: file://www.census.gov/prod/2011pubs/12statab/defense.pdf (Accessed on March 29, 2012).",
"    </li>",
"    <li>",
"     armypubs.army.mil/epubs/pdf/r40_501.pdf (Accessed on February 03, 2011).",
"    </li>",
"    <li>",
"     www.benefits.va.gov/warms/bookc.asp#h (Accessed on February 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/115\">",
"      Finley EP, Zeber JE, Pugh MJ, et al. Postdeployment health care for returning OEF/OIF military personnel and their social networks: a qualitative approach. Mil Med 2010; 175:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/116\">",
"      McFarlane AC. Military deployment: the impact on children and family adjustment and the need for care. Curr Opin Psychiatry 2009; 22:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/117\">",
"      Flake EM, Davis BE, Johnson PL, Middleton LS. The psychosocial effects of deployment on military children. J Dev Behav Pediatr 2009; 30:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/118\">",
"      Walker S. Assessing the mental health consequences of military combat in Iraq and Afghanistan: a literature review. J Psychiatr Ment Health Nurs 2010; 17:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/5/28762/abstract/119\">",
"      Sayer NA, Noorbaloochi S, Frazier P, et al. Reintegration problems and treatment interests among Iraq and Afghanistan combat veterans receiving VA medical care. Psychiatr Serv 2010; 61:589.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15782 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28762=[""].join("\n");
var outline_f28_5_28762=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H616481677\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3796084\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3796170\">",
"      PHYSICAL INJURY DUE TO COMBAT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3796184\">",
"      Amputations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3796191\">",
"      Traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H617393371\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3796198\">",
"      PSYCHOLOGICAL SEQUELAE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H341622647\">",
"      Posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H341622527\">",
"      Depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H341622519\">",
"      Generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770042\">",
"      Suicide risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3796205\">",
"      Psychological complications of amputation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3796212\">",
"      Psychological complications of traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2154256\">",
"      CHRONIC PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H283153424\">",
"      SUBSTANCE ABUSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4770835\">",
"      INFECTIOUS DISEASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770842\">",
"      Malaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770849\">",
"      Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H73400661\">",
"      Wound infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H73400668\">",
"      - Antibiotic resistant bacteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770856\">",
"      Cutaneous leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770863\">",
"      Visceral leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770870\">",
"      Q fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770906\">",
"      Brucellosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770913\">",
"      Anthrax and smallpox vaccinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46284381\">",
"      Transfusion-related infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4770934\">",
"      ENVIRONMENTAL HAZARDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46284479\">",
"      Noise exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4770942\">",
"      Toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4769426\">",
"      DISABILITY AND FUNCTIONAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46283896\">",
"      SOCIAL STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H616481677\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/15782\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/15782|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?31/27/32191\" title=\"algorithm 1\">",
"      Diagnosis anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/15782|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?13/7/13429\" title=\"form 1\">",
"      PTSD checklist military",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?16/39/17013\" title=\"form 2\">",
"      PTSD checklist civilian",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/15782|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/62/29676\" title=\"table 1\">",
"      Glasgow coma scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/12/14541\" title=\"table 2\">",
"      PHQ-9 questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/30/32236\" title=\"table 3\">",
"      GAD-7 anxiety scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/58/18342?source=related_link\">",
"      Anthrax vaccine adsorbed: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37642?source=related_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19078?source=related_link\">",
"      Clinical assessment of wounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12502?source=related_link\">",
"      Clinical manifestations and diagnosis of Q fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21161?source=related_link\">",
"      Clinical manifestations and diagnosis of visceral leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=related_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of brucellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37761?source=related_link\">",
"      Clinical microbiology review: Wound, skin, and soft tissue infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29626?source=related_link\">",
"      Concussion and mild traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22873?source=related_link\">",
"      Disability assessment and determination in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/18/33063?source=related_link\">",
"      Epidemiology, clinical manifestations and diagnosis of cutaneous leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26727?source=related_link\">",
"      Etiology and diagnosis of tinnitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40296?source=related_link\">",
"      Evaluation of chronic pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/32/39429?source=related_link\">",
"      Evaluation of hearing loss in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30553?source=related_link\">",
"      Extended-spectrum beta-lactamases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6890?source=related_link\">",
"      Mucormycosis (zygomycosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4394?source=related_link\">",
"      Overview of non-falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42778?source=related_link\">",
"      Overview of the treatment of chronic pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=related_link\">",
"      Pharmacotherapy for generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33239?source=related_link\">",
"      Pharmacotherapy for posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33929?source=related_link\">",
"      Postconcussion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27352?source=related_link\">",
"      Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=related_link\">",
"      Procedures used for blood donor screening: Protection of potential blood donors and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5032?source=related_link\">",
"      Psychotherapy for posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=related_link\">",
"      Q fever endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/24/25993?source=related_link\">",
"      Screening for unhealthy use of alcohol and other drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/43/20152?source=related_link\">",
"      Skin lesions in the returning traveler",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=related_link\">",
"      Subacute and chronic low back pain: Pharmacologic and noninterventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10377?source=related_link\">",
"      Suicidal ideation and behavior in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39062?source=related_link\">",
"      Traumatic brain injury: Epidemiology, classification, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=related_link\">",
"      Treatment of resistant depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4745?source=related_link\">",
"      Using scales to monitor symptoms and treatment of depression (measurement based care)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/7/40057?source=related_link\">",
"      Vaccinia virus as the smallpox vaccine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_5_28763="Seasons of viral CNS infection";
var content_f28_5_28763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Seasonal incidence of viral CNS infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Peak time of year",
"       </td>",
"       <td class=\"subtitle1\">",
"        Aseptic meningitis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Viral encephalitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Summer/fall",
"       </td>",
"       <td class=\"sublist1_start\">",
"        <p>",
"         Enteroviruses:",
"        </p>",
"        <p>",
"         Coxsackie",
"        </p>",
"        <p>",
"         Echovirus",
"        </p>",
"        <p>",
"         Poliovirus",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         West Nile virus",
"        </p>",
"        <p>",
"         St Louis encephalitis virus",
"        </p>",
"        <p>",
"         Eastern equine encephalitis virus",
"        </p>",
"        <p>",
"         California encephalitis viruses",
"        </p>",
"        <p>",
"         Western equine encephalitis virus",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Winter/spring",
"       </td>",
"       <td>",
"        <p>",
"         Mumps",
"        </p>",
"        <br/>",
"        <p>",
"         Lymphocytic choriomeningitis virus",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Measles",
"        </p>",
"        <br/>",
"        <p>",
"         Mumps",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any season",
"       </td>",
"       <td>",
"        <p>",
"         Herpes simplex virus type 2",
"        </p>",
"        <p>",
"         HIV infection",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Herpes simplex virus type 1",
"        </p>",
"        <p>",
"         HIV infection",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28763=[""].join("\n");
var outline_f28_5_28763=null;
var title_f28_5_28764="Phases radiation injury";
var content_f28_5_28764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Phases of radiation injury",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Dose (Gy)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Symptoms",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Prognosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Prodrome",
"       </td>",
"       <td class=\"subtitle2\">",
"        Hematologic",
"       </td>",
"       <td class=\"subtitle2\">",
"        GI",
"       </td>",
"       <td class=\"subtitle2\">",
"        Neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0.5 to 1.0",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Survival almost certain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1.0 to 2.0",
"       </td>",
"       <td>",
"        +/++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Survival &gt;90 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2.0 to 3.5",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Probable survival",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3.5 to 5.5",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Death in 50 percent&nbsp;at 3.5 to 6 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5.5 to 7.5",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        Death probable in 2 to 3 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7.5 to 10",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        0*",
"       </td>",
"       <td>",
"        Death probable in 1 to 2.5 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10 to 20",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        Death certain in 5 to 12 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;20",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Death certain in 2 to 5 days",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Gy: dose in Grey; GI: gastrointestinal side effects; 0: no effects; +: mild; ++: moderate; +++: severe or marked.",
"     <br>",
"      * Hypotension.",
"      <br>",
"       &bull; Also cardiovascular collapse, fever, shock.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome: Recommendations of the strategic national stockpile radiation working group. Ann Int Med 2004; 140:1039.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28764=[""].join("\n");
var outline_f28_5_28764=null;
var title_f28_5_28765="Exercise and CHD PI";
var content_f28_5_28765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F54004&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F54004&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary heart disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 314px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronary events are less frequent among those who exercise. In a study of 5159 men, aged 40 to 49 years, followed for an average of almost 19 years, the age-adjusted coronary heart disease event rate per 1000 person-years is lower in those who perform any physical activity compared to inactive subjects.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Wannamethee, SG, Shaper, AG, Alberti, KG, Arch Intern Med 2000; 160:2108.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28765=[""].join("\n");
var outline_f28_5_28765=null;
var title_f28_5_28766="Hemoglobin absorption spectra";
var content_f28_5_28766=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Hemoglobin absorption spectra",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 405px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The oxyhemoglobin (Hb02) contained within red blood cells has three major absorption peaks at 418, 542, and 577 nm, with an additional infrared absorption around 1000 nm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scott Prahl. Available at:",
"     <a href=\"file://omlc.ogi.edu/spectra/hemoglobin/\">",
"      file://omlc.ogi.edu/spectra/hemoglobin/",
"     </a>",
"     . Copyright &copy; 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28766=[""].join("\n");
var outline_f28_5_28766=null;
var title_f28_5_28767="RHS classic arm position PI";
var content_f28_5_28767=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F86687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F86687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arm position for Nursemaid's elbow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 401px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Children with nursemaid's elbow usually hold their injured arm close to their body. They keep their elbow straight or slightly bent, and their palm facing down.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_5_28767=[""].join("\n");
var outline_f28_5_28767=null;
